{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:19:14Z","timestamp":1777213154687,"version":"3.51.4"},"reference-count":332,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00204-021-03171-4","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T03:02:27Z","timestamp":1635822147000},"page":"11-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-0681","authenticated-orcid":false,"given":"Ana","family":"Dias-Carvalho","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Maria de Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"Susana Isabel","family":"S\u00e1","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Capela","sequence":"additional","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-2756","authenticated-orcid":false,"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"issue":"2","key":"3171_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/03610730902720497","volume":"35","author":"CE Adams-Price","year":"2009","unstructured":"Adams-Price CE, Morse LW, Cross GW, Williams M, Wells-Parker E (2009) The effects of chemotherapy on Useful Field of View (UFOV) in younger and older breast cancer patients. Exp Aging Res 35(2):220\u2013234. https:\/\/doi.org\/10.1080\/03610730902720497","journal-title":"Exp Aging Res"},{"issue":"3","key":"3171_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","volume":"7","author":"TA Ahles","year":"2007","unstructured":"Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7(3):192. https:\/\/doi.org\/10.1038\/nrc2073","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3171_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1200\/jco.2002.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA, Saykin AJ, Furstenberg CT et al (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2):485\u2013493. https:\/\/doi.org\/10.1200\/jco.2002.20.2.485","journal-title":"J Clin Oncol"},{"issue":"29","key":"3171_CR4","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1200\/jco.2009.27.0827","volume":"28","author":"TA Ahles","year":"2010","unstructured":"Ahles TA, Saykin AJ, McDonald BC et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434\u20134440. https:\/\/doi.org\/10.1200\/jco.2009.27.0827","journal-title":"J Clin Oncol"},{"issue":"6","key":"3171_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/pon.742","volume":"12","author":"TA Ahles","year":"2003","unstructured":"Ahles TA, Saykin AJ, Noll WW et al (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12(6):612\u2013619. https:\/\/doi.org\/10.1002\/pon.742","journal-title":"Psychooncology"},{"issue":"6","key":"3171_CR6","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1523\/JNEUROSCI.23-06-02008.2003","volume":"23","author":"M Akil","year":"2003","unstructured":"Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE (2003) Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23(6):2008\u20132013. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-06-02008.2003","journal-title":"J Neurosci"},{"key":"3171_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/syn.22085","author":"TC Alexander","year":"2018","unstructured":"Alexander TC, Kiffer F, Groves T et al (2018) Effects of thioTEPA chemotherapy on cognition and motor coordination. Synapse. https:\/\/doi.org\/10.1002\/syn.22085","journal-title":"Synapse"},{"key":"3171_CR8","doi-asserted-by":"publisher","unstructured":"Alharbi I, Alharbi H, Almogbel Y, Alalwan A, Alhowail A (2020) Effect of Metformin on Doxorubicin-Induced Memory Dysfunction. Brain Sci 10(3) https:\/\/doi.org\/10.3390\/brainsci10030152","DOI":"10.3390\/brainsci10030152"},{"issue":"21","key":"3171_CR9","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.26355\/eurrev_201911_19460","volume":"23","author":"AH Alhowail","year":"2019","unstructured":"Alhowail AH, Chigurupati S, Sajid S, Mani V (2019) Ameliorative effect of metformin on cyclophosphamide-induced memory impairment in mice. Eur Rev Med Pharmacol Sci 23(21):9660\u20139666. https:\/\/doi.org\/10.26355\/eurrev_201911_19460","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3171_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108334","volume":"181","author":"MA Ali","year":"2020","unstructured":"Ali MA, Menze ET, Tadros MG, Tolba MF (2020) Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation. Neuropharmacology 181:108334. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108334","journal-title":"Neuropharmacology"},{"issue":"1","key":"3171_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s40478-019-0838-8","volume":"7","author":"BD Allen","year":"2019","unstructured":"Allen BD, Apodaca LA, Syage AR et al (2019) Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments. Acta Neuropathol Commun 7(1):186. https:\/\/doi.org\/10.1186\/s40478-019-0838-8","journal-title":"Acta Neuropathol Commun"},{"key":"3171_CR12","doi-asserted-by":"publisher","unstructured":"Almeida D, Pinho R, Correia V, et al. (2018) Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study. Pharmaceuticals (Basel) 11(2) doi:https:\/\/doi.org\/10.3390\/ph11020041","DOI":"10.3390\/ph11020041"},{"issue":"11","key":"3171_CR13","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.freeradbiomed.2011.03.009","volume":"50","author":"CD Aluise","year":"2011","unstructured":"Aluise CD, Miriyala S, Noel T et al (2011) 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-\u03b1 release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radic Biol Med 50(11):1630\u20131638. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.03.009","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3171_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2009.02.047","volume":"282","author":"CD Aluise","year":"2009","unstructured":"Aluise CD, St Clair D, Vore M, Butterfield DA (2009) In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE). Cancer Lett 282(1):25\u201329. https:\/\/doi.org\/10.1016\/j.canlet.2009.02.047","journal-title":"Cancer Lett"},{"issue":"3","key":"3171_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11682-016-9552-3","volume":"11","author":"A Amidi","year":"2017","unstructured":"Amidi A, Agerbaek M, Wu LM et al (2017) Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging Behav 11(3):769\u2013783. https:\/\/doi.org\/10.1007\/s11682-016-9552-3","journal-title":"Brain Imaging Behav"},{"issue":"10","key":"3171_CR16","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00520-015-2663-3","volume":"23","author":"A Amidi","year":"2015","unstructured":"Amidi A, Wu LM, Pedersen AD et al (2015) Cognitive impairment in testicular cancer survivors 2\u20137\u00a0years after treatment. Support Care Cancer 23(10):2973\u20132979. https:\/\/doi.org\/10.1007\/s00520-015-2663-3","journal-title":"Support Care Cancer"},{"issue":"7","key":"3171_CR17","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/nrn1434","volume":"10","author":"JK Andersen","year":"2004","unstructured":"Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10(7):S18\u2013S25. https:\/\/doi.org\/10.1038\/nrn1434","journal-title":"Nat Med"},{"key":"3171_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.116644","volume":"410","author":"DE Anderson","year":"2020","unstructured":"Anderson DE, Kedar S, Bhatt VR, Schmid K, Holstein SA, Rizzo M (2020) Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: a feasibility study. J Neurol Sci 410:116644. https:\/\/doi.org\/10.1016\/j.jns.2019.116644","journal-title":"J Neurol Sci"},{"issue":"4","key":"3171_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12282-012-0405-7","volume":"21","author":"N Ando-Tanabe","year":"2014","unstructured":"Ando-Tanabe N, Iwamitsu Y, Kuranami M et al (2014) Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls. Breast Cancer 21(4):453\u2013462. https:\/\/doi.org\/10.1007\/s12282-012-0405-7","journal-title":"Breast Cancer"},{"issue":"2","key":"3171_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00520-012-1560-2","volume":"21","author":"F Andreis","year":"2013","unstructured":"Andreis F, Ferri M, Mazzocchi M et al (2013) Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A Pilot Study. Support Care Cancer 21(2):583\u2013590. https:\/\/doi.org\/10.1007\/s00520-012-1560-2","journal-title":"A Pilot Study. Support Care Cancer"},{"key":"3171_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.expneurol.2014.02.020","volume":"255","author":"AL Andres","year":"2014","unstructured":"Andres AL, Gong X, Di K, Bota DA (2014) Low-doses of cisplatin injure hippocampal synapses: a mechanism for \u201cchemo\u201d brain? Exp Neurol 255:137\u2013144. https:\/\/doi.org\/10.1016\/j.expneurol.2014.02.020","journal-title":"Exp Neurol"},{"issue":"3","key":"3171_CR22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.pharep.2016.01.009","volume":"68","author":"L Antkiewicz-Michaluk","year":"2016","unstructured":"Antkiewicz-Michaluk L, Krzemieniecki K, Romanska I, Michaluk J, Krygowska-Wajs A (2016) Acute treatment with doxorubicin induced neurochemical impairment of the function of dopamine system in rat brain structures. Pharmacol Rep 68(3):627\u2013630. https:\/\/doi.org\/10.1016\/j.pharep.2016.01.009","journal-title":"Pharmacol Rep"},{"issue":"2","key":"3171_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/0284186X.2016.1266089","volume":"56","author":"V Arndt","year":"2017","unstructured":"Arndt V, Koch-Gallenkamp L, Jansen L et al (2017) Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol 56(2):190\u2013197","journal-title":"Acta Oncol"},{"issue":"2","key":"3171_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-014-3092-6","volume":"147","author":"MK Askren","year":"2014","unstructured":"Askren MK, Jung M, Berman MG et al (2014) Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat 147(2):445\u2013455. https:\/\/doi.org\/10.1007\/s10549-014-3092-6","journal-title":"Breast Cancer Res Treat"},{"key":"3171_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4137\/bcbcr.s6957","volume":"5","author":"M Ayala-Feliciano","year":"2011","unstructured":"Ayala-Feliciano M, Pons-Valerio JJ, Pons-Madera J, Acevedo SF (2011) The relationship between visuospatial memory and coping strategies in breast cancer survivors. Breast Cancer (auckl) 5:117\u2013130. https:\/\/doi.org\/10.4137\/bcbcr.s6957","journal-title":"Breast Cancer (auckl)"},{"issue":"11","key":"3171_CR26","doi-asserted-by":"publisher","first-page":"3494S","DOI":"10.1093\/jn\/132.11.3494S","volume":"132","author":"NM Aziz","year":"2002","unstructured":"Aziz NM (2002) Cancer survivorship research: challenge and opportunity. J Nutr 132(11):3494S\u20133503S. https:\/\/doi.org\/10.1093\/jn\/132.11.3494S","journal-title":"J Nutr"},{"issue":"10","key":"3171_CR27","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56(10):7159\u20137172. https:\/\/doi.org\/10.1007\/s12035-019-1589-z","journal-title":"Mol Neurobiol"},{"issue":"4","key":"3171_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1039\/C4TX00043A","volume":"4","author":"DJ Barbosa","year":"2015","unstructured":"Barbosa DJ, Capela JP, de Lourdes BM, Carvalho F (2015) In vitro models for neurotoxicology research. Toxicology Research 4(4):801\u2013842. https:\/\/doi.org\/10.1039\/C4TX00043A","journal-title":"Toxicology Research"},{"key":"3171_CR29","unstructured":"Barkoukis TJ (2012) Sleep-Related Medical Disorders. In: Blumer J (ed) Therapy in Sleep Medicine. 1st edn. Elsevier\/Saunders, p 607\u2013615"},{"issue":"6","key":"3171_CR30","first-page":"559","volume":"56","author":"B Baudino","year":"2012","unstructured":"Baudino B, D\u2019Agata F, Caroppo P et al (2012) The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. Q J Nucl Med Mol Imaging 56(6):559\u2013568","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"3171_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3109\/07380577.2010.533251","volume":"25","author":"MF Baxter","year":"2011","unstructured":"Baxter MF, Dulworth AN, Smith TM (2011) Identification of mild cognitive impairments in cancer survivors. Occup Ther Health Care 25(1):26\u201337. https:\/\/doi.org\/10.3109\/07380577.2010.533251","journal-title":"Occup Ther Health Care"},{"issue":"2","key":"3171_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1188\/15.cjon.180-184","volume":"19","author":"H Becker","year":"2015","unstructured":"Becker H, Henneghan A, Mikan SQ (2015) When do I get my brain back? Breast cancer survivors\u2019 experiences of cognitive problems. Clin J Oncol Nurs 19(2):180\u2013184. https:\/\/doi.org\/10.1188\/15.cjon.180-184","journal-title":"Clin J Oncol Nurs"},{"issue":"5","key":"3171_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/pon.964","volume":"15","author":"CM Bender","year":"2006","unstructured":"Bender CM, Sereika SM, Berga SL et al (2006) Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 15(5):422\u2013430. https:\/\/doi.org\/10.1002\/pon.964","journal-title":"Psychooncology"},{"key":"3171_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/320941","volume":"2015","author":"A Bhowmik","year":"2015","unstructured":"Bhowmik A, Khan R, Ghosh MK (2015) Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int 2015:320941. https:\/\/doi.org\/10.1155\/2015\/320941","journal-title":"Biomed Res Int"},{"issue":"4","key":"3171_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2354.2011.01320.x","volume":"21","author":"N Biglia","year":"2012","unstructured":"Biglia N, Bounous VE, Malabaila A et al (2012) Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (engl) 21(4):485\u2013492. https:\/\/doi.org\/10.1111\/j.1365-2354.2011.01320.x","journal-title":"Eur J Cancer Care (engl)"},{"issue":"17","key":"3171_CR36","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1002\/hbm.24753","volume":"40","author":"J Blommaert","year":"2019","unstructured":"Blommaert J, Schroyen G, Vandenbulcke M et al (2019) Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients. Hum Brain Mapp 40(17):4994\u20135010. https:\/\/doi.org\/10.1002\/hbm.24753","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"3171_CR37","first-page":"1735","volume":"33","author":"RS Bourke","year":"1973","unstructured":"Bourke RS, West CR, Chheda G, Tower DB (1973) Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res 33(7):1735\u20131746","journal-title":"Cancer Res"},{"issue":"34","key":"3171_CR38","doi-asserted-by":"publisher","first-page":"23426","DOI":"10.18632\/oncotarget.25193","volume":"9","author":"JJV Branca","year":"2018","unstructured":"Branca JJV, Maresca M, Morucci G et al (2018) Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity. Oncotarget 9(34):23426\u201323438. https:\/\/doi.org\/10.18632\/oncotarget.25193","journal-title":"Oncotarget"},{"issue":"6","key":"3171_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"3171_CR40","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1200\/jco.2000.18.14.2695","volume":"18","author":"CB Brezden","year":"2000","unstructured":"Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18(14):2695\u20132701. https:\/\/doi.org\/10.1200\/jco.2000.18.14.2695","journal-title":"J Clin Oncol"},{"key":"3171_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2013.07.175","volume":"35","author":"TL Briones","year":"2014","unstructured":"Briones TL, Woods J (2014) Dysregulation in myelination mediated by persistent neuroinflammation: possible mechanisms in chemotherapy-related cognitive impairment. Brain Behav Immun 35:23\u201332. https:\/\/doi.org\/10.1016\/j.bbi.2013.07.175","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3171_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2012.07.009","volume":"48","author":"J Bruno","year":"2012","unstructured":"Bruno J, Hosseini SM, Kesler S (2012) Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis 48(3):329\u2013338. https:\/\/doi.org\/10.1016\/j.nbd.2012.07.009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3171_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JOM.0b013e3181d0bef7","volume":"52","author":"L Calvio","year":"2010","unstructured":"Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M (2010) Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 52(2):219\u2013227. https:\/\/doi.org\/10.1097\/JOM.0b013e3181d0bef7","journal-title":"J Occup Environ Med"},{"key":"3171_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112233","volume":"378","author":"CV Cardoso","year":"2020","unstructured":"Cardoso CV, de Barros MP, Bachi ALL et al (2020) Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration. Behavioural Brain Res 378:112233. https:\/\/doi.org\/10.1016\/j.bbr.2019.112233","journal-title":"Behavioural Brain Res"},{"key":"3171_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-020-00950-3","author":"H Carreira","year":"2020","unstructured":"Carreira H, Williams R, Dempsey H, Stanway S, Smeeth L, Bhaskaran K (2020) Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom. J Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-020-00950-3","journal-title":"J Cancer Surviv"},{"issue":"2","key":"3171_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/cncr.31777","volume":"125","author":"JE Carroll","year":"2019","unstructured":"Carroll JE, Van Dyk K, Bower JE et al (2019) Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer 125(2):298\u2013306. https:\/\/doi.org\/10.1002\/cncr.31777","journal-title":"Cancer"},{"issue":"1","key":"3171_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-008-0211-2","volume":"116","author":"S Castellon","year":"2009","unstructured":"Castellon S, Ganz PA (2009) Neuropsychological studies in breast cancer: in search of chemobrain. Breast Cancer Res Treat 116(1):125\u2013127. https:\/\/doi.org\/10.1007\/s10549-008-0211-2","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"3171_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/13803390490510905","volume":"26","author":"SA Castellon","year":"2004","unstructured":"Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA (2004) Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26(7):955\u2013969. https:\/\/doi.org\/10.1080\/13803390490510905","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"3171_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/13803395.2018.1546381","volume":"41","author":"N Cerulla","year":"2019","unstructured":"Cerulla N, Arcusa A, Navarro JB et al (2019) Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results. J Clin Exp Neuropsychol 41(3):290\u2013299. https:\/\/doi.org\/10.1080\/13803395.2018.1546381","journal-title":"J Clin Exp Neuropsychol"},{"issue":"1","key":"3171_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10549-017-4240-6","volume":"164","author":"N Cerulla","year":"2017","unstructured":"Cerulla N, Arcusa A, Navarro JB et al (2017) Role of taxanes in chemotherapy-related cognitive impairment: a prospective longitudinal study. Breast Cancer Res Treat 164(1):179\u2013187. https:\/\/doi.org\/10.1007\/s10549-017-4240-6","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3171_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10549-018-4911-y","volume":"172","author":"BT Chen","year":"2018","unstructured":"Chen BT, Jin T, Patel SK et al (2018) Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treat 172(2):363\u2013370. https:\/\/doi.org\/10.1007\/s10549-018-4911-y","journal-title":"Breast Cancer Res Treat"},{"key":"3171_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2019.09.016","author":"BT Chen","year":"2019","unstructured":"Chen BT, Ye N, Wong CW et al (2019) Effects of chemotherapy on aging white matter microstructure: a longitudinal diffusion tensor imaging study. J Geriatr Oncol. https:\/\/doi.org\/10.1016\/j.jgo.2019.09.016","journal-title":"J Geriatr Oncol"},{"issue":"2","key":"3171_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jgo.2019.09.016","volume":"11","author":"BT Chen","year":"2020","unstructured":"Chen BT, Ye N, Wong CW et al (2020a) Effects of chemotherapy on aging white matter microstructure: a longitudinal diffusion tensor imaging study. J Geriatr Oncol 11(2):290\u2013296. https:\/\/doi.org\/10.1016\/j.jgo.2019.09.016","journal-title":"J Geriatr Oncol"},{"issue":"5","key":"3171_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232548","volume":"15","author":"VC Chen","year":"2020","unstructured":"Chen VC, Lin KY, Tsai YH, Weng JC (2020b) Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy. PLoS ONE 15(5):e0232548. https:\/\/doi.org\/10.1371\/journal.pone.0232548","journal-title":"PLoS ONE"},{"issue":"10","key":"3171_CR55","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/pon.3539","volume":"23","author":"X Chen","year":"2014","unstructured":"Chen X, Li J, Ren J et al (2014) Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment. Psychooncology 23(10):1165\u20131171. https:\/\/doi.org\/10.1002\/pon.3539","journal-title":"Psychooncology"},{"issue":"3","key":"3171_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1124\/mi.7.3.6","volume":"7","author":"Y Chen","year":"2007","unstructured":"Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK (2007) Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interventions 7(3):147. https:\/\/doi.org\/10.1124\/mi.7.3.6","journal-title":"Mol Interventions"},{"key":"3171_CR57","doi-asserted-by":"publisher","first-page":"45135","DOI":"10.1038\/srep45135","volume":"7","author":"H Cheng","year":"2017","unstructured":"Cheng H, Li W, Gong L et al (2017) Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors. Sci Rep 7:45135. https:\/\/doi.org\/10.1038\/srep45135","journal-title":"Sci Rep"},{"issue":"10","key":"3171_CR58","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/pon.3291","volume":"22","author":"H Cheng","year":"2013","unstructured":"Cheng H, Yang Z, Dong B et al (2013) Chemotherapy-induced prospective memory impairment in patients with breast cancer. Psychooncology 22(10):2391\u20132395. https:\/\/doi.org\/10.1002\/pon.3291","journal-title":"Psychooncology"},{"issue":"7","key":"3171_CR59","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Ng T, Shwe M et al (2015) Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol 26(7):1446\u20131451. https:\/\/doi.org\/10.1093\/annonc\/mdv206","journal-title":"Ann Oncol"},{"issue":"3","key":"3171_CR60","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/0008-5472.can-16-1817","volume":"77","author":"GS Chiu","year":"2017","unstructured":"Chiu GS, Maj MA, Rizvi S et al (2017) Pifithrin-mu Prevents cisplatin-induced chemobrain by preserving neuronal mitochondrial function. Cancer Res 77(3):742\u2013752. https:\/\/doi.org\/10.1158\/0008-5472.can-16-1817","journal-title":"Cancer Res"},{"issue":"3","key":"3171_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3346\/jkms.2001.16.3.328","volume":"16","author":"SM Choi","year":"2001","unstructured":"Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH (2001) 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci 16(3):328\u2013334. https:\/\/doi.org\/10.3346\/jkms.2001.16.3.328","journal-title":"J Korean Med Sci"},{"issue":"7","key":"3171_CR62","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1158\/1078-0432.ccr-11-2000","volume":"18","author":"LA Christie","year":"2012","unstructured":"Christie LA, Acharya MM, Parihar VK, Nguyen A, Martirosian V, Limoli CL (2012) Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 18(7):1954\u20131965. https:\/\/doi.org\/10.1158\/1078-0432.ccr-11-2000","journal-title":"Clin Cancer Res"},{"issue":"7","key":"3171_CR63","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/pon.3163","volume":"22","author":"B Collins","year":"2013","unstructured":"Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A (2013) Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psychooncology 22(7):1517\u20131527. https:\/\/doi.org\/10.1002\/pon.3163","journal-title":"Psychooncology"},{"issue":"4","key":"3171_CR64","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1017\/s1355617713001215","volume":"20","author":"B Collins","year":"2014","unstructured":"Collins B, Mackenzie J, Tasca GA, Scherling C, Smith A (2014) Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy. J Int Neuropsychol Soc 20(4):370\u2013379. https:\/\/doi.org\/10.1017\/s1355617713001215","journal-title":"J Int Neuropsychol Soc"},{"key":"3171_CR65","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"3171_CR66","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1534735404270335","volume":"3","author":"KA Conklin","year":"2004","unstructured":"Conklin KA (2004) Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 3(4):294\u2013300. https:\/\/doi.org\/10.1177\/1534735404270335","journal-title":"Integr Cancer Ther"},{"issue":"6","key":"3171_CR67","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1200\/jco.2005.06.050","volume":"23","author":"T Conroy","year":"2005","unstructured":"Conroy T, Paillot B, Francois E et al (2005) Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer\u2013a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study. J Clin Oncol 23(6):1228\u20131236. https:\/\/doi.org\/10.1200\/jco.2005.06.050","journal-title":"J Clin Oncol"},{"issue":"6","key":"3171_CR68","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s11682-016-9608-4","volume":"11","author":"DD Correa","year":"2017","unstructured":"Correa DD, Root JC, Kryza-Lacombe M et al (2017) Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study. Brain Imaging Behav 11(6):1652\u20131663. https:\/\/doi.org\/10.1007\/s11682-016-9608-4","journal-title":"Brain Imaging Behav"},{"issue":"2","key":"3171_CR69","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ygyno.2010.06.023","volume":"119","author":"DD Correa","year":"2010","unstructured":"Correa DD, Zhou Q, Thaler HT, Maziarz M, Hurley K, Hensley ML (2010) Cognitive functions in long-term survivors of ovarian cancer. Gynecol Oncol 119(2):366\u2013369. https:\/\/doi.org\/10.1016\/j.ygyno.2010.06.023","journal-title":"Gynecol Oncol"},{"issue":"7","key":"3171_CR70","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00520-014-2147-x","volume":"22","author":"JA Cruzado","year":"2014","unstructured":"Cruzado JA, Lopez-Santiago S, Martinez-Marin V, Jose-Moreno G, Custodio AB, Feliu J (2014) Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients. Support Care Cancer 22(7):1815\u20131823. https:\/\/doi.org\/10.1007\/s00520-014-2147-x","journal-title":"Support Care Cancer"},{"issue":"10","key":"3171_CR71","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/bjc.1996.608","volume":"74","author":"A Cull","year":"1996","unstructured":"Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M (1996) What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 74(10):1674\u20131679","journal-title":"Br J Cancer"},{"issue":"3","key":"3171_CR72","doi-asserted-by":"publisher","first-page":"393","DOI":"10.13075\/mp.5893.00137","volume":"66","author":"M Czerska","year":"2015","unstructured":"Czerska M, Mikolajewska K, Zielinski M, Gromadzinska J, Wasowicz W (2015) Today\u2019s oxidative stress markers. Med Pr 66(3):393\u2013405. https:\/\/doi.org\/10.13075\/mp.5893.00137","journal-title":"Med Pr"},{"issue":"6","key":"3171_CR73","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2174\/1871520615666150407155319","volume":"15","author":"M da Ros","year":"2015","unstructured":"da Ros M, Iorio AL, Lucchesi M, Stival A, de Martino M, Sardi I (2015) The Use of Anthracyclines for Therapy of CNS Tumors. Anticancer Agents Med Chem 15(6):721\u2013727. https:\/\/doi.org\/10.2174\/1871520615666150407155319","journal-title":"Anticancer Agents Med Chem"},{"key":"3171_CR74","doi-asserted-by":"publisher","unstructured":"Davis BD, Fernandez F, Adams F, et al. (1987) Diagnosis of dementia in cancer patients. Cognitive impairment in these patients can go unrecognized. Psychosomatics 28(4):175\u20139 https:\/\/doi.org\/10.1016\/s0033-3182(87)72542-0","DOI":"10.1016\/s0033-3182(87)72542-0"},{"issue":"3","key":"3171_CR75","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10926-013-9474-5","volume":"24","author":"AG de Boer","year":"2014","unstructured":"de Boer AG (2014) The European cancer and work network: CANWON. J Occup Rehabil 24(3):393\u2013398. https:\/\/doi.org\/10.1007\/s10926-013-9474-5","journal-title":"J Occup Rehabil"},{"issue":"11","key":"3171_CR76","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","volume":"44","author":"ME de Jonge","year":"2005","unstructured":"de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH (2005) Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinetics 44(11):1135\u20131164. https:\/\/doi.org\/10.2165\/00003088-200544110-00003","journal-title":"Clin Pharmacokinetics"},{"issue":"12","key":"3171_CR77","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/hbm.21422","volume":"33","author":"MB de Ruiter","year":"2012","unstructured":"de Ruiter MB, Reneman L, Boogerd W et al (2012) Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 33(12):2971\u20132983. https:\/\/doi.org\/10.1002\/hbm.21422","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"3171_CR78","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/hbm.21102","volume":"32","author":"MB de Ruiter","year":"2011","unstructured":"de Ruiter MB, Reneman L, Boogerd W et al (2011) Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 32(8):1206\u20131219. https:\/\/doi.org\/10.1002\/hbm.21102","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"3171_CR79","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1586\/14737175.6.8.1199","volume":"6","author":"NA de Vries","year":"2006","unstructured":"de Vries NA, Beijnen JH, Boogerd W, van Tellingen O (2006) Blood-brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother 6(8):1199\u20131209. https:\/\/doi.org\/10.1586\/14737175.6.8.1199","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"3171_CR80","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-010-0756-8","volume":"121","author":"J Debess","year":"2010","unstructured":"Debess J, Riis JO, Engebjerg MC, Ewertz M (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121(1):91\u2013100. https:\/\/doi.org\/10.1007\/s10549-010-0756-8","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3171_CR81","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/jco.2011.36.8571","volume":"30","author":"S Deprez","year":"2012","unstructured":"Deprez S, Amant F, Smeets A et al (2012) Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol 30(3):274\u2013281. https:\/\/doi.org\/10.1200\/jco.2011.36.8571","journal-title":"J Clin Oncol"},{"issue":"3","key":"3171_CR82","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/hbm.21033","volume":"32","author":"S Deprez","year":"2011","unstructured":"Deprez S, Amant F, Yigit R et al (2011) Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp 32(3):480\u2013493. https:\/\/doi.org\/10.1002\/hbm.21033","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"3171_CR83","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11682-012-9220-1","volume":"7","author":"S Deprez","year":"2013","unstructured":"Deprez S, Billiet T, Sunaert S, Leemans A (2013) Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review. Brain Imaging Behav 7(4):409\u2013435. https:\/\/doi.org\/10.1007\/s11682-012-9220-1","journal-title":"Brain Imaging Behav"},{"issue":"19","key":"3171_CR84","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1200\/jco.2013.53.6219","volume":"32","author":"S Deprez","year":"2014","unstructured":"Deprez S, Vandenbulcke M, Peeters R et al (2014) Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. J Clin Oncol 32(19):2031\u20132038. https:\/\/doi.org\/10.1200\/jco.2013.53.6219","journal-title":"J Clin Oncol"},{"issue":"7","key":"3171_CR85","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/jbiol50","volume":"5","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 5(7):22. https:\/\/doi.org\/10.1186\/jbiol50","journal-title":"J Biol"},{"issue":"11","key":"3171_CR86","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/cncr.21482","volume":"104","author":"KA Donovan","year":"2005","unstructured":"Donovan KA, Small BJ, Andrykowski MA, Schmitt FA, Munster P, Jacobsen PB (2005) Cognitive functioning after adjuvant chemotherapy and\/or radiotherapy for early-stage breast carcinoma. Cancer 104(11):2499\u20132507. https:\/\/doi.org\/10.1002\/cncr.21482","journal-title":"Cancer"},{"issue":"1","key":"3171_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12944-016-0288-2","volume":"15","author":"J Dose","year":"2016","unstructured":"Dose J, Huebbe P, Nebel A, Rimbach G (2016) APOE genotype and stress response-a mini review. Lipids Health Dis 15(1):121. https:\/\/doi.org\/10.1186\/s12944-016-0288-2","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3171_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/COC.0b013e3181b9cf1b","volume":"33","author":"XL Du","year":"2010","unstructured":"Du XL, Xia R, Hardy D (2010) Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am J Clin Oncol 33(6):533\u2013543. https:\/\/doi.org\/10.1097\/COC.0b013e3181b9cf1b","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"3171_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/spc.0000000000000248","volume":"11","author":"SF Duijts","year":"2017","unstructured":"Duijts SF, van der Beek AJ, Boelhouwer IG, Schagen SB (2017) Cancer-related cognitive impairment and patients\u2019 ability to work: a current perspective. Curr Opin Support Palliat Care 11(1):19\u201323. https:\/\/doi.org\/10.1097\/spc.0000000000000248","journal-title":"Curr Opin Support Palliat Care"},{"issue":"4","key":"3171_CR90","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11682-013-9244-1","volume":"7","author":"JA Dumas","year":"2013","unstructured":"Dumas JA, Makarewicz J, Schaubhut GJ et al (2013) Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav 7(4):524\u2013532. https:\/\/doi.org\/10.1007\/s11682-013-9244-1","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"3171_CR91","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00520-005-0894-4","volume":"14","author":"B Eberhardt","year":"2006","unstructured":"Eberhardt B, Dilger S, Musial F, Wedding U, Weiss T, Miltner WH (2006) Medium-term effects of chemotherapy in older cancer patients. Support Care Cancer 14(3):216\u2013222. https:\/\/doi.org\/10.1007\/s00520-005-0894-4","journal-title":"Support Care Cancer"},{"issue":"1","key":"3171_CR92","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuroimage.2003.08.037","volume":"21","author":"JL Eberling","year":"2004","unstructured":"Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ (2004) Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 21(1):364\u2013371. https:\/\/doi.org\/10.1016\/j.neuroimage.2003.08.037","journal-title":"Neuroimage"},{"issue":"5","key":"3171_CR93","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jgo.2018.02.010","volume":"9","author":"BJ Edwards","year":"2018","unstructured":"Edwards BJ, Zhang X, Sun M et al (2018) Neurocognitive deficits in older patients with cancer. J Geriatr Oncol 9(5):482\u2013487. https:\/\/doi.org\/10.1016\/j.jgo.2018.02.010","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"3171_CR94","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/clpt.1982.135","volume":"32","author":"MJ Egorin","year":"1982","unstructured":"Egorin MJ, Kaplan RS, Salcman M et al (1982) Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide. Clin Pharmacol Therapeutics 32(1):122\u2013128","journal-title":"Clin Pharmacol Therapeutics"},{"issue":"2","key":"3171_CR95","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11764-019-00839-w","volume":"14","author":"JK Ehrenstein","year":"2020","unstructured":"Ehrenstein JK, van Zon SKR, Duijts SFA et al (2020) Type of cancer treatment and cognitive symptoms in working cancer survivors: an 18-month follow-up study. J Cancer Surviv 14(2):158\u2013167. https:\/\/doi.org\/10.1007\/s11764-019-00839-w","journal-title":"J Cancer Surviv"},{"issue":"1","key":"3171_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-019-03827-0","volume":"84","author":"SE El-Agamy","year":"2019","unstructured":"El-Agamy SE, Abdel-Aziz AK, Esmat A, Azab SS (2019) Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemother Pharmacol 84(1):1\u201314. https:\/\/doi.org\/10.1007\/s00280-019-03827-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"3171_CR97","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1007\/s12035-017-0797-7","volume":"55","author":"SE El-Agamy","year":"2018","unstructured":"El-Agamy SE, Abdel-Aziz AK, Wahdan S, Esmat A, Azab SS (2018) Astaxanthin ameliorates doxorubicin-induced cognitive impairment (Chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries. Mol Neurobiol 55(7):5727\u20135740. https:\/\/doi.org\/10.1007\/s12035-017-0797-7","journal-title":"Mol Neurobiol"},{"issue":"5","key":"3171_CR186","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.brainresbull.2012.05.005","volume":"88","author":"M El","year":"2012","unstructured":"El M, Mustafa S, Umka J et al (2012) The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus. Brain Res Bull 88(5):514\u2013518. https:\/\/doi.org\/10.1016\/j.brainresbull.2012.05.005","journal-title":"Brain Res Bull"},{"issue":"31","key":"3171_CR98","doi-asserted-by":"publisher","first-page":"8025","DOI":"10.1200\/jco.2005.01.6550","volume":"23","author":"HG Fan","year":"2005","unstructured":"Fan HG, Houede-Tchen N, Yi QL et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 23(31):8025\u20138032. https:\/\/doi.org\/10.1200\/jco.2005.01.6550","journal-title":"J Clin Oncol"},{"issue":"2","key":"3171_CR99","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/pon.1372","volume":"18","author":"HG Fan","year":"2009","unstructured":"Fan HG, Park A, Xu W et al (2009) The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psychooncology 18(2):156\u2013161. https:\/\/doi.org\/10.1002\/pon.1372","journal-title":"Psychooncology"},{"issue":"1","key":"3171_CR100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40644-020-00355-6","volume":"20","author":"Y Feng","year":"2020","unstructured":"Feng Y, Wang YF, Zheng LJ, Shi Z, Huang W, Zhang LJ (2020) Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study. Cancer Imaging 20(1):73. https:\/\/doi.org\/10.1186\/s40644-020-00355-6","journal-title":"Cancer Imaging"},{"issue":"12","key":"3171_CR101","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749\u20131768. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996","journal-title":"JAMA Oncol"},{"issue":"10 Suppl","key":"3171_CR102","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/cncr.1984.53.s10.2250","volume":"53","author":"MF Folstein","year":"1984","unstructured":"Folstein MF, Fetting JH, Lobo A, Niaz U, Capozzoli KD (1984) Cognitive assessment of cancer patients. Cancer 53(10 Suppl):2250\u20132257","journal-title":"Cancer"},{"issue":"Suppl 3","key":"3171_CR103","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.3816\/CBC.2002.s.019","volume":"3","author":"JR Freeman","year":"2002","unstructured":"Freeman JR, Broshek DK (2002) Assessing cognitive dysfunction in breast cancer: what are the tools? Clin Breast Cancer 3(Suppl 3):S91\u2013S99","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"3171_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082331","volume":"9","author":"PJ Gaillard","year":"2014","unstructured":"Gaillard PJ, Appeldoorn CC, Dorland R et al (2014) Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3\u2013101). PloS one 9(1):e82331. https:\/\/doi.org\/10.1371\/journal.pone.0082331","journal-title":"PloS one"},{"key":"3171_CR105","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/b978-0-7020-4088-7.00077-8","volume":"121","author":"J Gallego Perez-Larraya","year":"2014","unstructured":"Gallego Perez-Larraya J, Hildebrand J (2014) Brain metastases. Handbook Clin Neurol 121:1143\u20131157. https:\/\/doi.org\/10.1016\/b978-0-7020-4088-7.00077-8","journal-title":"Handbook Clin Neurol"},{"key":"3171_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/428010","volume":"2012","author":"S Gandhi","year":"2012","unstructured":"Gandhi S, Abramov AY (2012) Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012: https:\/\/doi.org\/10.1155\/2012\/428010","journal-title":"Oxid Med Cell Longev"},{"key":"3171_CR107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnins.2013.00063","volume":"7","author":"A Garthe","year":"2013","unstructured":"Garthe A, Kempermann G (2013) An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis. Front Neurosci 7:63. https:\/\/doi.org\/10.3389\/fnins.2013.00063","journal-title":"Front Neurosci"},{"issue":"1","key":"3171_CR108","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11060-014-1543-x","volume":"120","author":"A Gerstenecker","year":"2014","unstructured":"Gerstenecker A, Nabors LB, Meneses K et al (2014) Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neuro-Oncol 120(1):179\u2013185. https:\/\/doi.org\/10.1007\/s11060-014-1543-x","journal-title":"J Neuro-Oncol"},{"issue":"1\u20132","key":"3171_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","volume":"176","author":"EM Gibson","year":"2019","unstructured":"Gibson EM, Nagaraja S, Ocampo A et al (2019) Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment. Cell 176(1\u20132):43-55.e13. https:\/\/doi.org\/10.1016\/j.cell.2018.10.049","journal-title":"Cell"},{"issue":"1","key":"3171_CR110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221(1):3\u201312. https:\/\/doi.org\/10.1002\/path.2697","journal-title":"J Pathol"},{"issue":"5","key":"3171_CR111","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ntt.2012.06.002","volume":"34","author":"KV Gopal","year":"2012","unstructured":"Gopal KV, Wu C, Shrestha B, Campbell KC, Moore EJ, Gross GW (2012) d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks. Neurotoxicol Teratol 34(5):495\u2013504. https:\/\/doi.org\/10.1016\/j.ntt.2012.06.002","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"3171_CR112","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/1097-0142(1967)20:5<896::aid-cncr2820200551>3.0.co;2-d","volume":"20","author":"EH Graul","year":"1967","unstructured":"Graul EH, Schaumloffel E, Hundeshagen H, Wilmanns H, Simon G (1967) Metabolism of radioactive cyclophosphamide Animal tests and clinical studies. Cancer 20(5):896\u2013899. https:\/\/doi.org\/10.1002\/1097-0142(1967)20:5%3c896::aid-cncr2820200551%3e3.0.co;2-d","journal-title":"Cancer"},{"issue":"4","key":"3171_CR113","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/jco.2005.02.4067","volume":"24","author":"ER Greimel","year":"2006","unstructured":"Greimel ER, Bjelic-Radisic V, Pfisterer J, Hilpert F, Daghofer F, du Bois A (2006) Randomized study of the arbeitsgemeinschaft gynaekologische onkologie ovarian cancer study group comparing quality of life in patients with ovarian cancer treated with cisplatin\/paclitaxel versus carboplatin\/paclitaxel. J Clin Oncol 24(4):579\u2013586. https:\/\/doi.org\/10.1200\/jco.2005.02.4067","journal-title":"J Clin Oncol"},{"issue":"1","key":"3171_CR114","first-page":"20","volume":"9","author":"W Grisold","year":"2017","unstructured":"Grisold W, Grisold A, L\u00f6scher W (2017) Cancer therapy and neuromuscular complications: a mini review. Neurology (ECronicon) 9(1):20\u201326","journal-title":"Neurology (ECronicon)"},{"key":"3171_CR115","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-1-0716-0471-7_32","volume":"2138","author":"PC Guest","year":"2020","unstructured":"Guest PC (2020) MK-801 treatment of oligodendrocytes as a cellular model of aging. Methods Mol Biol (clifton, NJ) 2138:431\u2013447. https:\/\/doi.org\/10.1007\/978-1-0716-0471-7_32","journal-title":"Methods Mol Biol (clifton, NJ)"},{"issue":"1\u20132","key":"3171_CR116","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cell.2018.12.027","volume":"176","author":"DH Gutmann","year":"2019","unstructured":"Gutmann DH (2019) Clearing the Fog surrounding Chemobrain. Cell 176(1\u20132):2\u20134. https:\/\/doi.org\/10.1016\/j.cell.2018.12.027","journal-title":"Cell"},{"issue":"10","key":"3171_CR117","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1517\/17425255.4.10.1265","volume":"4","author":"GJ Harry","year":"2008","unstructured":"Harry GJ, Kraft AD (2008) Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol 4(10):1265\u20131277. https:\/\/doi.org\/10.1517\/17425255.4.10.1265","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9350","key":"3171_CR118","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","volume":"360","author":"H-P Hartung","year":"2002","unstructured":"Hartung H-P, Gonsette R, Konig N et al (2002) Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 360(9350):2018\u20132025. https:\/\/doi.org\/10.1016\/S0140-6736(02)12023-X","journal-title":"Lancet"},{"issue":"9","key":"3171_CR119","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1532-5415.2008.01848.x","volume":"56","author":"JE Heck","year":"2008","unstructured":"Heck JE, Albert SM, Franco R, Gorin SS (2008) Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy. J Am Geriatr Soc 56(9):1687\u20131692. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01848.x","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"3171_CR120","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/dji137","volume":"97","author":"LH Heflin","year":"2005","unstructured":"Heflin LH, Meyerowitz BE, Hall P et al (2005) Cancer as a risk factor for long-term cognitive deficits and dementia. J Natl Cancer Inst 97(11):854\u2013856. https:\/\/doi.org\/10.1093\/jnci\/dji137","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3171_CR121","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s12640-019-00158-z","volume":"37","author":"A Henneghan","year":"2020","unstructured":"Henneghan A, Rao V, Harrison RA et al (2020) Cortical brain age from pre-treatment to post-chemotherapy in patients with breast cancer. Neurotox Res 37(4):788\u2013799. https:\/\/doi.org\/10.1007\/s12640-019-00158-z","journal-title":"Neurotox Res"},{"key":"3171_CR122","doi-asserted-by":"publisher","unstructured":"Hermelink K (2011) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 117(5):1103; author reply 1103\u20134 doi:https:\/\/doi.org\/10.1002\/cncr.25708","DOI":"10.1002\/cncr.25708"},{"issue":"12","key":"3171_CR123","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/pon.1695","volume":"19","author":"K Hermelink","year":"2010","unstructured":"Hermelink K, Kuchenhoff H, Untch M et al (2010) Two different sides of \u201cchemobrain\u201d: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19(12):1321\u20131328. https:\/\/doi.org\/10.1002\/pon.1695","journal-title":"Psychooncology"},{"issue":"6","key":"3171_CR124","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3816\/cbc.2002.s.019","volume":"8","author":"LM Hess","year":"2010","unstructured":"Hess LM, Chambers SK, Hatch K et al (2010) Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer. J Support Oncol 8(6):252\u2013258. https:\/\/doi.org\/10.3816\/cbc.2002.s.019","journal-title":"J Support Oncol"},{"issue":"3","key":"3171_CR125","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ygyno.2015.10.003","volume":"139","author":"LM Hess","year":"2015","unstructured":"Hess LM, Huang HQ, Hanlon AL et al (2015) Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology\/gynecologic oncology group study. Gynecol Oncol 139(3):541\u2013545. https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.003","journal-title":"Gynecol Oncol"},{"key":"3171_CR126","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2377-12-28","volume":"12","author":"SM Hosseini","year":"2012","unstructured":"Hosseini SM, Koovakkattu D, Kesler SR (2012) Altered small-world properties of gray matter networks in breast cancer. BMC Neurol 12:28. https:\/\/doi.org\/10.1186\/1471-2377-12-28","journal-title":"BMC Neurol"},{"issue":"1","key":"3171_CR127","doi-asserted-by":"publisher","first-page":"17400","DOI":"10.1038\/s41598-018-35919-x","volume":"8","author":"X Huo","year":"2018","unstructured":"Huo X, Reyes TM, Heijnen CJ, Kavelaars A (2018) Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice. Sci Rep 8(1):17400. https:\/\/doi.org\/10.1038\/s41598-018-35919-x","journal-title":"Sci Rep"},{"issue":"3","key":"3171_CR128","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-006-9171-6","volume":"98","author":"A Hurria","year":"2006","unstructured":"Hurria A, Goldfarb S, Rosen C et al (2006a) Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient\u2019s perspective. Breast Cancer Res Treat 98(3):343\u2013348. https:\/\/doi.org\/10.1007\/s10549-006-9171-6","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3171_CR129","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1532-5415.2006.00732.x","volume":"54","author":"A Hurria","year":"2006","unstructured":"Hurria A, Rosen C, Hudis C et al (2006b) Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 54(6):925\u2013931. https:\/\/doi.org\/10.1111\/j.1532-5415.2006.00732.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"3171_CR130","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2354.2007.00857.x","volume":"17","author":"G Iconomou","year":"2008","unstructured":"Iconomou G, Koutras A, Karaivazoglou K et al (2008) Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. Eur J Cancer Care (engl) 17(6):535\u2013541. https:\/\/doi.org\/10.1111\/j.1365-2354.2007.00857.x","journal-title":"Eur J Cancer Care (engl)"},{"key":"3171_CR131","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00280-009-1085-7","volume":"65","author":"S Jacobs","year":"2009","unstructured":"Jacobs S, McCully C, Murphy R, Bacher J, Balis F, Fox E (2009) Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Cancer Chemotherapy Pharmacol 65:817\u2013824. https:\/\/doi.org\/10.1007\/s00280-009-1085-7","journal-title":"Cancer Chemotherapy Pharmacol"},{"issue":"5","key":"3171_CR132","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00280-009-1085-7","volume":"65","author":"S Jacobs","year":"2010","unstructured":"Jacobs S, McCully CL, Murphy RF, Bacher J, Balis FM, Fox E (2010) Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Cancer Chemotherapy Pharmacol 65(5):817\u2013824. https:\/\/doi.org\/10.1007\/s00280-009-1085-7","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"3171_CR133","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuro.2016.06.013","volume":"56","author":"MC Janelsins","year":"2016","unstructured":"Janelsins MC, Heckler CE, Thompson BD, Gross RA, Opanashuk LA, Cory-Slechta DA (2016) A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age. Neurotoxicology 56:287\u2013293. https:\/\/doi.org\/10.1016\/j.neuro.2016.06.013","journal-title":"Neurotoxicology"},{"issue":"5","key":"3171_CR134","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3109\/07357900903405942","volume":"28","author":"MC Janelsins","year":"2010","unstructured":"Janelsins MC, Roscoe JA, Berg MJ et al (2010) IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL\/6 mice. Cancer Invest 28(5):544\u2013553. https:\/\/doi.org\/10.3109\/07357900903405942","journal-title":"Cancer Invest"},{"issue":"6","key":"3171_CR135","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1188\/05.onf.1151-1163","volume":"32","author":"C Jansen","year":"2005","unstructured":"Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32(6):1151\u20131163. https:\/\/doi.org\/10.1188\/05.onf.1151-1163","journal-title":"Oncol Nurs Forum"},{"issue":"10","key":"3171_CR136","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00520-010-0997-4","volume":"19","author":"CE Jansen","year":"2011","unstructured":"Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19(10):1647\u20131656. https:\/\/doi.org\/10.1007\/s00520-010-0997-4","journal-title":"Support Care Cancer"},{"issue":"12","key":"3171_CR137","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/pon.1342","volume":"17","author":"CE Jansen","year":"2008","unstructured":"Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J (2008) Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psychooncology 17(12):1189\u20131195. https:\/\/doi.org\/10.1002\/pon.1342","journal-title":"Psychooncology"},{"issue":"5","key":"3171_CR138","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1188\/07.onf.997-1005","volume":"34","author":"CE Jansen","year":"2007","unstructured":"Jansen CE, Miaskowski CA, Dodd MJ, Dowling GA (2007) A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncol Nurs Forum 34(5):997\u20131005. https:\/\/doi.org\/10.1188\/07.onf.997-1005","journal-title":"Oncol Nurs Forum"},{"key":"3171_CR139","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbr.2019.01.007","volume":"362","author":"DP Jarmolowicz","year":"2019","unstructured":"Jarmolowicz DP, Gehringer R, Lemley SM, Sofis MJ, Kaplan S, Johnson MA (2019) 5-Fluorouracil impairs attention and dopamine release in rats. Behav Brain Res 362:319\u2013322. https:\/\/doi.org\/10.1016\/j.bbr.2019.01.007","journal-title":"Behav Brain Res"},{"issue":"6","key":"3171_CR140","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/sj.bjc.6603029","volume":"94","author":"V Jenkins","year":"2006","unstructured":"Jenkins V, Shilling V, Deutsch G et al (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94(6):828\u2013834. https:\/\/doi.org\/10.1038\/sj.bjc.6603029","journal-title":"Br J Cancer"},{"issue":"8","key":"3171_CR141","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/cncr.24192","volume":"115","author":"HS Jim","year":"2009","unstructured":"Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115(8):1776\u20131783. https:\/\/doi.org\/10.1002\/cncr.24192","journal-title":"Cancer"},{"issue":"5","key":"3171_CR142","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1054\/bjoc.2000.1337","volume":"83","author":"F Joly","year":"2000","unstructured":"Joly F, Espie M, Marty M, Heron JF, Henry-Amar M (2000) Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy. Br J Cancer 83(5):577\u2013582. https:\/\/doi.org\/10.1054\/bjoc.2000.1337","journal-title":"Br J Cancer"},{"issue":"3","key":"3171_CR143","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jnr.21158","volume":"85","author":"G Joshi","year":"2007","unstructured":"Joshi G, Hardas S, Sultana R, St Clair DK, Vore M, Butterfield DA (2007) Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain. J Neurosci Res 85(3):497\u2013503. https:\/\/doi.org\/10.1002\/jnr.21158","journal-title":"J Neurosci Res"},{"issue":"3","key":"3171_CR144","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1097\/NCC.0b013e3182980383","volume":"37","author":"MS Jung","year":"2014","unstructured":"Jung MS, Cimprich B (2014) Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Cancer Nurs 37(3):E31-42. https:\/\/doi.org\/10.1097\/NCC.0b013e3182980383","journal-title":"Cancer Nurs"},{"issue":"1","key":"3171_CR145","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11682-016-9507-8","volume":"11","author":"MS Jung","year":"2017","unstructured":"Jung MS, Zhang M, Askren MK et al (2017) Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis. Brain Imaging Behav 11(1):86\u201397. https:\/\/doi.org\/10.1007\/s11682-016-9507-8","journal-title":"Brain Imaging Behav"},{"key":"3171_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101654","volume":"21","author":"O Kardan","year":"2019","unstructured":"Kardan O, Reuter-Lorenz PA, Peltier S et al (2019) Brain connectivity tracks effects of chemotherapy separately from behavioral measures. Neuroimage Clin 21:101654. https:\/\/doi.org\/10.1016\/j.nicl.2019.101654","journal-title":"Neuroimage Clin"},{"issue":"8","key":"3171_CR147","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng2070","volume":"39","author":"CM Kassmann","year":"2007","unstructured":"Kassmann CM, Lappe-Siefke C, Baes M et al (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39(8):969\u2013976. https:\/\/doi.org\/10.1038\/ng2070","journal-title":"Nat Genet"},{"issue":"54","key":"3171_CR148","doi-asserted-by":"publisher","first-page":"30324","DOI":"10.18632\/oncotarget.25718","volume":"9","author":"JTR Keeney","year":"2018","unstructured":"Keeney JTR, Ren X, Warrier G et al (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d). Oncotarget 9(54):30324\u201330339. https:\/\/doi.org\/10.18632\/oncotarget.25718","journal-title":"Oncotarget"},{"issue":"Suppl","key":"3171_CR149","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","volume":"30","author":"S Kesler","year":"2013","unstructured":"Kesler S, Janelsins M, Koovakkattu D et al (2013a) Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun 30(Suppl):S109\u2013S116. https:\/\/doi.org\/10.1016\/j.bbi.2012.05.017","journal-title":"Brain Behav Immun"},{"issue":"28","key":"3171_CR151","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1073\/pnas.1214551110","volume":"110","author":"SR Kesler","year":"2013","unstructured":"Kesler SR, Wefel JS, Hosseini SM, Cheung M, Watson CL, Hoeft F (2013b) Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci USA 110(28):11600\u201311605. https:\/\/doi.org\/10.1073\/pnas.1214551110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3171_CR150","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaoncol.2015.4333","volume":"2","author":"SR Kesler","year":"2016","unstructured":"Kesler SR, Blayney DW (2016) Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol 2(2):185\u2013192. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4333","journal-title":"JAMA Oncol"},{"key":"3171_CR152","doi-asserted-by":"crossref","unstructured":"Kettenmann H, Verkhratsky A (2013) Glial cells. Neuroscience in the 21st Century: From Basic to Clinical:475\u2013506","DOI":"10.1007\/978-1-4614-1997-6_19"},{"key":"3171_CR153","doi-asserted-by":"crossref","unstructured":"Khan HA, Khan I, Lee Y-k (2018) Role of immune factors in bioavailability and toxicity of carbon nanomaterials Fullerens, Graphenes and Nanotubes. Elsevier, p 601\u2013630","DOI":"10.1016\/B978-0-12-813691-1.00015-4"},{"issue":"1","key":"3171_CR154","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12885-019-5349-2","volume":"19","author":"OF Khan","year":"2019","unstructured":"Khan OF, Cusano E, Raissouni S et al (2019) Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study. BMC Cancer 19(1):150. https:\/\/doi.org\/10.1186\/s12885-019-5349-2","journal-title":"BMC Cancer"},{"issue":"7","key":"3171_CR155","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s00330-016-4578-x","volume":"27","author":"HG Kim","year":"2017","unstructured":"Kim HG, Shin NY, Bak Y et al (2017) Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: a preliminary study. Eur Radiol 27(7):2679\u20132688. https:\/\/doi.org\/10.1007\/s00330-016-4578-x","journal-title":"Eur Radiol"},{"issue":"1","key":"3171_CR156","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/jjco\/hyi214","volume":"36","author":"YA Kim","year":"2006","unstructured":"Kim YA, Chung HC, Choi HJ, Rha SY, Seong JS, Jeung HC (2006) Intermediate dose 5-fluorouracil-induced encephalopathy. Jpn J Clin Oncol 36(1):55\u201359. https:\/\/doi.org\/10.1093\/jjco\/hyi214","journal-title":"Jpn J Clin Oncol"},{"key":"3171_CR157","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbr.2015.06.007","volume":"292","author":"Y Kitamura","year":"2015","unstructured":"Kitamura Y, Hattori S, Yoneda S et al (2015) Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation. Behav Brain Res 292:184\u2013193. https:\/\/doi.org\/10.1016\/j.bbr.2015.06.007","journal-title":"Behav Brain Res"},{"issue":"12","key":"3171_CR158","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/cncr.24287","volume":"115","author":"S Kohli","year":"2009","unstructured":"Kohli S, Fisher SG, Tra Y et al (2009) The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115(12):2605\u20132616. https:\/\/doi.org\/10.1002\/cncr.24287","journal-title":"Cancer"},{"issue":"2","key":"3171_CR159","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jgo.2019.11.007","volume":"11","author":"TT Koll","year":"2020","unstructured":"Koll TT, Sheese AN, Semin J et al (2020) Screening for cognitive impairment in older adults with hematological malignancies using the montreal cognitive assessment and neuropsychological testing. J Geriatr Oncol 11(2):297\u2013303. https:\/\/doi.org\/10.1016\/j.jgo.2019.11.007","journal-title":"J Geriatr Oncol"},{"issue":"10","key":"3171_CR160","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1200\/jco.2011.37.0189","volume":"30","author":"V Koppelmans","year":"2012","unstructured":"Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012a) Neuropsychological performance in survivors of breast cancer more than 20\u00a0years after adjuvant chemotherapy. J Clin Oncol 30(10):1080\u20131086. https:\/\/doi.org\/10.1200\/jco.2011.37.0189","journal-title":"J Clin Oncol"},{"issue":"3","key":"3171_CR161","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10549-011-1888-1","volume":"132","author":"V Koppelmans","year":"2012","unstructured":"Koppelmans V, de Ruiter MB, van der Lijn F et al (2012b) Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 132(3):1099\u20131106. https:\/\/doi.org\/10.1007\/s10549-011-1888-1","journal-title":"Breast Cancer Res Treat"},{"issue":"51","key":"3171_CR162","doi-asserted-by":"publisher","first-page":"88276","DOI":"10.18632\/oncotarget.19835","volume":"8","author":"A Kovalchuk","year":"2017","unstructured":"Kovalchuk A, Ilnytskyy Y, Rodriguez-Juarez R et al (2017) Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice. Oncotarget 8(51):88276\u201388293. https:\/\/doi.org\/10.18632\/oncotarget.19835","journal-title":"Oncotarget"},{"issue":"1","key":"3171_CR163","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3816\/CBC.2006.n.015","volume":"7","author":"BP Kreukels","year":"2006","unstructured":"Kreukels BP, Schagen SB, Ridderinkhof KR et al (2006) Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Clin Breast Cancer 7(1):67\u201378. https:\/\/doi.org\/10.3816\/CBC.2006.n.015","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"3171_CR164","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10549-005-7093-3","volume":"94","author":"BP Kreukels","year":"2005","unstructured":"Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS (2005) Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 94(1):53\u201361. https:\/\/doi.org\/10.1007\/s10549-005-7093-3","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3171_CR165","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/gerona\/glr140","volume":"66","author":"K Kurita","year":"2011","unstructured":"Kurita K, Meyerowitz BE, Hall P, Gatz M (2011) Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment. J Gerontol A Biol Sci Med Sci 66(12):1343\u20131349. https:\/\/doi.org\/10.1093\/gerona\/glr140","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"3171_CR166","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1007\/s11064-016-1949-2","volume":"41","author":"M Kwatra","year":"2016","unstructured":"Kwatra M, Jangra A, Mishra M et al (2016) Naringin and sertraline ameliorate doxorubicin-induced behavioral deficits through modulation of serotonin level and mitochondrial complexes protection pathway in rat hippocampus. Neurochem Res 41(9):2352\u20132366. https:\/\/doi.org\/10.1007\/s11064-016-1949-2","journal-title":"Neurochem Res"},{"issue":"2","key":"3171_CR167","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4143\/crt.2010.42.2.118","volume":"42","author":"KA Kwon","year":"2010","unstructured":"Kwon KA, Kwon HC, Kim MC et al (2010) A case of 5-fluorouracil induced encephalopathy. Cancer Res Treat 42(2):118\u2013120. https:\/\/doi.org\/10.4143\/crt.2010.42.2.118","journal-title":"Cancer Res Treat"},{"issue":"11","key":"3171_CR168","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1634\/theoncologist.2016-0014","volume":"21","author":"M Lange","year":"2016","unstructured":"Lange M, Heutte N, Rigal O et al (2016) Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist 21(11):1337\u20131348. https:\/\/doi.org\/10.1634\/theoncologist.2016-0014","journal-title":"Oncologist"},{"key":"3171_CR169","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/2193-1801-3-444","volume":"3","author":"C Lepage","year":"2014","unstructured":"Lepage C, Smith AM, Moreau J et al (2014) A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. Springerplus 3:444. https:\/\/doi.org\/10.1186\/2193-1801-3-444","journal-title":"Springerplus"},{"key":"3171_CR170","doi-asserted-by":"crossref","unstructured":"Levine PM, Silberfarb PM, Lipowski Z (1978) Mental disorders in cancer patients. A study of 100 psychiatric referrals. Cancer 42(3):1385\u20131391","DOI":"10.1002\/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0"},{"issue":"1","key":"3171_CR171","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1186\/s12885-018-5113-z","volume":"18","author":"TY Li","year":"2018","unstructured":"Li TY, Chen VC, Yeh DC et al (2018a) Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis. BMC Cancer 18(1):1211. https:\/\/doi.org\/10.1186\/s12885-018-5113-z","journal-title":"BMC Cancer"},{"issue":"1","key":"3171_CR172","doi-asserted-by":"publisher","first-page":"13801","DOI":"10.1038\/s41598-018-32257-w","volume":"8","author":"X Li","year":"2018","unstructured":"Li X, Chen H, Lv Y et al (2018b) Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients. Sci Rep 8(1):13801. https:\/\/doi.org\/10.1038\/s41598-018-32257-w","journal-title":"Sci Rep"},{"issue":"8","key":"3171_CR173","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159734","volume":"11","author":"Y Libert","year":"2016","unstructured":"Libert Y, Dubruille S, Borghgraef C et al (2016) Vulnerabilities in older patients when cancer treatment is initiated: does a cognitive impairment impact the two-year survival? PLoS ONE 11(8):e0159734. https:\/\/doi.org\/10.1371\/journal.pone.0159734","journal-title":"PLoS ONE"},{"issue":"2","key":"3171_CR174","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pbb.2009.09.001","volume":"94","author":"PE Liedke","year":"2009","unstructured":"Liedke PE, Reolon GK, Kilpp B, Brunetto AL, Roesler R, Schwartsmann G (2009) Systemic administration of doxorubicin impairs aversively motivated memory in rats. Pharmacol Biochem Behav 94(2):239\u2013243. https:\/\/doi.org\/10.1016\/j.pbb.2009.09.001","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"3171_CR175","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/1073858405280524","volume":"11","author":"DE Linden","year":"2005","unstructured":"Linden DE (2005) The p300: where in the brain is it produced and what does it tell us? Neuroscientist 11(6):563\u2013576. https:\/\/doi.org\/10.1177\/1073858405280524","journal-title":"Neuroscientist"},{"key":"3171_CR176","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2016.11.046","volume":"102","author":"N Lomeli","year":"2017","unstructured":"Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA (2017) Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radic Biol Med 102:274\u2013286. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.11.046","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3171_CR177","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pbb.2011.08.012","volume":"100","author":"JM Long","year":"2011","unstructured":"Long JM, Lee GD, Kelley-Bell B et al (2011) Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacol Biochem Behav 100(1):205\u2013211. https:\/\/doi.org\/10.1016\/j.pbb.2011.08.012","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"3171_CR178","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12640-009-9135-9","volume":"19","author":"M\u00c2 Lopes","year":"2011","unstructured":"Lopes M\u00c2, Meisel A, Carvalho F, Bastos ML (2011) Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons. Neurotoxicity Res 19(1):14\u201322. https:\/\/doi.org\/10.1007\/s12640-009-9135-9","journal-title":"Neurotoxicity Res"},{"issue":"2","key":"3171_CR179","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuro.2007.12.003","volume":"29","author":"M\u00c2 Lopes","year":"2008","unstructured":"Lopes M\u00c2, Meisel A, Dirnagl U, Carvalho F, Bastos ML (2008) Doxorubicin induces biphasic neurotoxicity to rat cortical neurons. Neurotoxicology 29(2):286\u2013293. https:\/\/doi.org\/10.1016\/j.neuro.2007.12.003","journal-title":"Neurotoxicology"},{"issue":"4","key":"3171_CR180","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11682-012-9213-0","volume":"7","author":"RA Lopez Zunini","year":"2013","unstructured":"Lopez Zunini RA, Scherling C, Wallis N et al (2013) Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav 7(4):460\u2013477. https:\/\/doi.org\/10.1007\/s11682-012-9213-0","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"3171_CR181","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2(1):86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2.1.86","journal-title":"NeuroRx"},{"issue":"Suppl. 1","key":"3171_CR182","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000086183","volume":"14","author":"Y Luqmani","year":"2005","unstructured":"Luqmani Y (2005) Mechanisms of drug resistance in cancer chemotherapy. Med Principles Pract 14(Suppl. 1):35\u201348. https:\/\/doi.org\/10.1159\/000086183","journal-title":"Med Principles Pract"},{"key":"3171_CR183","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2016.11.002","volume":"301","author":"DE Lyon","year":"2016","unstructured":"Lyon DE, Cohen R, Chen H et al (2016) Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol 301:74\u201382. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.11.002","journal-title":"J Neuroimmunol"},{"issue":"6","key":"3171_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021445","volume":"6","author":"L Lyons","year":"2011","unstructured":"Lyons L, Elbeltagy M, Bennett G, Wigmore P (2011) The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat. PLoS ONE 6(6):e21445. https:\/\/doi.org\/10.1371\/journal.pone.0021445","journal-title":"PLoS ONE"},{"issue":"1","key":"3171_CR185","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030010","volume":"7","author":"L Lyons","year":"2012","unstructured":"Lyons L, ElBeltagy M, Bennett G, Wigmore P (2012) Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PLoS ONE 7(1):e30010. https:\/\/doi.org\/10.1371\/journal.pone.0030010","journal-title":"PLoS ONE"},{"key":"3171_CR187","unstructured":"Maiese K (2019) Neurotransmiss\u00e3o. In. Accessed 22\u201301\u20132021"},{"issue":"6","key":"3171_CR188","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00520-007-0341-9","volume":"16","author":"HG Mar Fan","year":"2008","unstructured":"Mar Fan HG, Clemons M, Xu W et al (2008) A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16(6):577\u2013583. https:\/\/doi.org\/10.1007\/s00520-007-0341-9","journal-title":"Support Care Cancer"},{"key":"3171_CR189","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fnhum.2012.00189","volume":"6","author":"RB Mars","year":"2012","unstructured":"Mars RB, Neubert F-X, Noonan MP, Sallet J, Toni I, Rushworth MF (2012) On the relationship between the \u201cdefault mode network\u201d and the \u201csocial brain\u201d. Front Hum Neurosci 6:189. https:\/\/doi.org\/10.3389\/fnhum.2012.00189","journal-title":"Front Hum Neurosci"},{"key":"3171_CR190","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neubiorev.2019.05.001","volume":"102","author":"A Matsos","year":"2019","unstructured":"Matsos A, Johnston IN (2019) Chemotherapy-induced cognitive impairments: a systematic review of the animal literature. Neurosci Biobehav Rev 102:382\u2013399. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.05.001","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"3171_CR191","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(16)30573-3","volume":"18","author":"DK Mayer","year":"2017","unstructured":"Mayer DK, Nasso SF, Earp JA (2017) Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol 18(1):e11\u2013e18. https:\/\/doi.org\/10.1016\/S1470-2045(16)30573-3","journal-title":"Lancet Oncol"},{"issue":"20","key":"3171_CR192","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/jco.2011.38.5674","volume":"30","author":"BC McDonald","year":"2012","unstructured":"McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ (2012) Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol 30(20):2500\u20132508. https:\/\/doi.org\/10.1200\/jco.2011.38.5674","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"3171_CR193","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","volume":"30","author":"BC McDonald","year":"2013","unstructured":"McDonald BC, Conroy SK, Smith DJ, West JD, Saykin AJ (2013) Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain Behav Immun 30(Suppl):S117\u2013S125. https:\/\/doi.org\/10.1016\/j.bbi.2012.05.007","journal-title":"Brain Behav Immun"},{"key":"3171_CR194","doi-asserted-by":"publisher","DOI":"10.1007\/s40211-020-00345-x","author":"K Megari","year":"2020","unstructured":"Megari K (2020) Neuropsychological functioning among patients with different types of cancer: Postchemotherapy cognitive impairment and implications for rehabilitation. Neuropsychiatr. https:\/\/doi.org\/10.1007\/s40211-020-00345-x","journal-title":"Neuropsychiatr"},{"issue":"3","key":"3171_CR195","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/pon.1398","volume":"18","author":"M Mehlsen","year":"2009","unstructured":"Mehlsen M, Pedersen AD, Jensen AB, Zachariae R (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18(3):248\u2013257. https:\/\/doi.org\/10.1002\/pon.1398","journal-title":"Psychooncology"},{"issue":"4","key":"3171_CR196","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jpainsymman.2016.04.012","volume":"52","author":"S Menning","year":"2016","unstructured":"Menning S, de Ruiter MB, Kieffer JM et al (2016) Cognitive impairment in a subset of breast cancer patients after systemic therapy-results from a longitudinal study. J Pain Symptom Manage 52(4):560-569.e1. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.04.012","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"3171_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171724","volume":"12","author":"S Menning","year":"2017","unstructured":"Menning S, de Ruiter MB, Veltman DJ et al (2017) Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. PLoS ONE 12(3):e0171724. https:\/\/doi.org\/10.1371\/journal.pone.0171724","journal-title":"PLoS ONE"},{"issue":"2","key":"3171_CR198","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11682-017-9695-x","volume":"12","author":"S Menning","year":"2018","unstructured":"Menning S, de Ruiter MB, Veltman DJ et al (2018) Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging Behav 12(2):324\u2013334. https:\/\/doi.org\/10.1007\/s11682-017-9695-x","journal-title":"Brain Imaging Behav"},{"issue":"4","key":"3171_CR199","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.21234","volume":"104","author":"CA Meyers","year":"2005","unstructured":"Meyers CA, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4):788\u2013793. https:\/\/doi.org\/10.1002\/cncr.21234","journal-title":"Cancer"},{"issue":"9","key":"3171_CR200","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00234-016-1708-8","volume":"58","author":"H Miao","year":"2016","unstructured":"Miao H, Chen X, Yan Y et al (2016) Functional connectivity change of brain default mode network in breast cancer patients after chemotherapy. Neuroradiology 58(9):921\u2013928. https:\/\/doi.org\/10.1007\/s00234-016-1708-8","journal-title":"Neuroradiology"},{"key":"3171_CR201","doi-asserted-by":"publisher","first-page":"2895972","DOI":"10.1155\/2016\/2895972","volume":"2016","author":"S Michalak","year":"2016","unstructured":"Michalak S, Rybacka-Mossakowska J, Ambrosius W et al (2016) The markers of glutamate metabolism in peripheral blood mononuclear cells and neurological complications in lung cancer patients. Dis Markers 2016:2895972. https:\/\/doi.org\/10.1155\/2016\/2895972","journal-title":"Dis Markers"},{"issue":"5","key":"3171_CR202","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, Mariotto AB et al (2019) (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69(5):363\u2013385. https:\/\/doi.org\/10.3322\/caac.21565","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3171_CR203","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS (2003) Blood-brain barrier disruption in multiple sclerosis. Multiple Sclerosis J 9(6):540\u2013549. https:\/\/doi.org\/10.1191\/1352458503ms965oa","journal-title":"Multiple Sclerosis J"},{"issue":"1","key":"3171_CR204","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.critrevonc.2008.02.004","volume":"67","author":"AM Minisini","year":"2008","unstructured":"Minisini AM, De Faccio S, Ermacora P et al (2008) Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study. Crit Rev Oncol Hematol 67(1):71\u201379. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.02.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"46","key":"3171_CR205","doi-asserted-by":"publisher","first-page":"81273","DOI":"10.18632\/oncotarget.18111","volume":"8","author":"C Mo","year":"2017","unstructured":"Mo C, Lin H, Fu F et al (2017) Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging. Oncotarget 8(46):81273\u201381284. https:\/\/doi.org\/10.18632\/oncotarget.18111","journal-title":"Oncotarget"},{"issue":"8","key":"3171_CR206","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00520-014-2197-0","volume":"22","author":"HC Moore","year":"2014","unstructured":"Moore HC, Parsons MW, Yue GH, Rybicki LA, Siemionow W (2014) Electroencephalogram power changes as a correlate of chemotherapy-associated fatigue and cognitive dysfunction. Supp Care Cancer 22(8):2127\u20132131. https:\/\/doi.org\/10.1007\/s00520-014-2197-0","journal-title":"Supp Care Cancer"},{"issue":"2","key":"3171_CR207","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.apmr.2017.06.016","volume":"99","author":"RT Morin","year":"2018","unstructured":"Morin RT, Midlarsky E (2018) Treatment with chemotherapy and cognitive functioning in older adult cancer survivors. Arch Phys Med Rehabil 99(2):257\u2013263. https:\/\/doi.org\/10.1016\/j.apmr.2017.06.016","journal-title":"Arch Phys Med Rehabil"},{"issue":"16","key":"3171_CR208","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/s0959-8049(03)00600-2","volume":"39","author":"R Morse","year":"2003","unstructured":"Morse R, Rodgers J, Verrill M, Kendell K (2003) Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. Eur J Cancer 39(16):2288\u20132297. https:\/\/doi.org\/10.1016\/s0959-8049(03)00600-2","journal-title":"Eur J Cancer"},{"issue":"12","key":"3171_CR209","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.18632\/aging.101144","volume":"8","author":"JF Moruno-Manchon","year":"2016","unstructured":"Moruno-Manchon JF, Uzor NE, Kesler SR et al (2016) TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging (albany NY) 8(12):3507\u20133519. https:\/\/doi.org\/10.18632\/aging.101144","journal-title":"Aging (albany NY)"},{"key":"3171_CR210","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13041-015-0125-y","volume":"8","author":"L Mu","year":"2015","unstructured":"Mu L, Wang J, Cao B et al (2015) Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex. Mol Brain 8:32. https:\/\/doi.org\/10.1186\/s13041-015-0125-y","journal-title":"Mol Brain"},{"issue":"2","key":"3171_CR211","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1460-9568.2008.06325.x","volume":"28","author":"S Mustafa","year":"2008","unstructured":"Mustafa S, Walker A, Bennett G, Wigmore PM (2008) 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 28(2):323\u2013330. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06325.x","journal-title":"Eur J Neurosci"},{"key":"3171_CR212","doi-asserted-by":"publisher","unstructured":"Muzzatti B, Giovannini L, Flaiban C, Cattaruzza N, Annunziata MA (2017) Cognitive functioning in long-term cancer survivorship: a survey utilizing both standardized neuropsychological and self-report measures. Appl Neuropsychol Adult:1\u20138 https:\/\/doi.org\/10.1080\/23279095.2017.1387551","DOI":"10.1080\/23279095.2017.1387551"},{"key":"3171_CR213","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4419-6306-2_9","volume":"678","author":"JS Myers","year":"2010","unstructured":"Myers JS (2010) Neuropsychologic testing for chemotherapy-related cognitive impairment. Chemo Fog. Adv Exp Med Biol 678:55\u201369. https:\/\/doi.org\/10.1007\/978-1-4419-6306-2_9","journal-title":"Chemo Fog. Adv Exp Med Biol"},{"key":"3171_CR214","doi-asserted-by":"publisher","unstructured":"Nandakumar K, Ramalingayya G, Nayak P, et al. (2018) Naringin ameliorates doxorubicin-induced neurotoxicity In vitro and cognitive dysfunction In vivo. Pharmacognosy Magazine 14(55):https:\/\/doi.org\/10.4103\/pm.pm_364_17","DOI":"10.4103\/pm.pm_364_17"},{"issue":"6","key":"3171_CR215","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1078-0432.ccr-14-2775","volume":"21","author":"A Natori","year":"2015","unstructured":"Natori A, Ogata T, Sumitani M, Kogure T, Yamauchi T, Yamauchi H (2015) Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment. Clin Cancer Res 21(6):1348\u20131352. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-2775","journal-title":"Clin Cancer Res"},{"key":"3171_CR216","first-page":"764","volume-title":"Bioenergetics and metabolism lehninger principles of biochemistry","author":"DL Nelson","year":"2013","unstructured":"Nelson DL, Cox MM (2013) Bioenergetics and metabolism lehninger principles of biochemistry, 6th edn. Macmillan Higher Education, pp 764\u2013765","edition":"6"},{"issue":"2","key":"3171_CR217","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/neuonc\/nov162","volume":"18","author":"T Ng","year":"2016","unstructured":"Ng T, Teo SM, Yeo HL et al (2016) Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro Oncol 18(2):244\u2013251. https:\/\/doi.org\/10.1093\/neuonc\/nov162","journal-title":"Neuro Oncol"},{"issue":"4","key":"3171_CR218","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/pon.3086","volume":"22","author":"CM Nguyen","year":"2013","unstructured":"Nguyen CM, Yamada TH, Beglinger LJ, Cavanaugh JE, Denburg NL, Schultz SK (2013) Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions. Psychooncology 22(4):862\u2013868. https:\/\/doi.org\/10.1002\/pon.3086","journal-title":"Psychooncology"},{"issue":"6","key":"3171_CR219","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012075","volume":"12","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Ehrlich BE (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med 12(6):e12075. https:\/\/doi.org\/10.15252\/emmm.202012075","journal-title":"EMBO Mol Med"},{"key":"3171_CR220","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/b978-0-12-811161-1.00006-2","volume":"149","author":"T Noh","year":"2018","unstructured":"Noh T, Walbert T (2018) Brain metastasis: clinical manifestations, symptom management, and palliative care. Handbook Clin Neurol 149:75\u201388. https:\/\/doi.org\/10.1016\/b978-0-12-811161-1.00006-2","journal-title":"Handbook Clin Neurol"},{"issue":"5","key":"3171_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096713","volume":"9","author":"KN Nudelman","year":"2014","unstructured":"Nudelman KN, Wang Y, McDonald BC et al (2014) Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusion. PLoS ONE 9(5):e96713. https:\/\/doi.org\/10.1371\/journal.pone.0096713","journal-title":"PLoS ONE"},{"issue":"10","key":"3171_CR222","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/0006-2952(95)00082-B","volume":"49","author":"T Ohnishi","year":"1995","unstructured":"Ohnishi T, Tamai I, Sakanaka K et al (1995) In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem Pharmacol 49(10):1541\u20131544","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3171_CR223","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1007\/s00520-018-4225-y","volume":"26","author":"I Olver","year":"2018","unstructured":"Olver I, Carey M, Boyes A et al (2018) The timeliness of patients reporting the side effects of chemotherapy. Supportive Care Cancer 26(10):3579\u20133586. https:\/\/doi.org\/10.1007\/s00520-018-4225-y","journal-title":"Supportive Care Cancer"},{"issue":"3","key":"3171_CR224","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/0742-969X.1986.11882570","volume":"2","author":"TE Oxman","year":"1986","unstructured":"Oxman TE, Schnurr PP, Silberfarb PM (1986) Assessment of cognitive function in cancer patients. Hosp J 2(3):99\u2013128","journal-title":"Hosp J"},{"issue":"10","key":"3171_CR225","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1176\/ajp.137.10.1263","volume":"137","author":"TE Oxman","year":"1980","unstructured":"Oxman TE, Silberfarb PM (1980) Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 137(10):1263\u20131265. https:\/\/doi.org\/10.1176\/ajp.137.10.1263","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3171_CR226","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/tbj.12862","volume":"24","author":"O Palesh","year":"2018","unstructured":"Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L (2018) Management of side effects during and post-treatment in breast cancer survivors. Breast J 24(2):167\u2013175. https:\/\/doi.org\/10.1111\/tbj.12862","journal-title":"Breast J"},{"issue":"3","key":"3171_CR227","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00280-005-0055-y","volume":"57","author":"SH Park","year":"2006","unstructured":"Park SH, Lee WK, Chung M et al (2006) Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy. Cancer Chemother Pharmacol 57(3):289\u2013294. https:\/\/doi.org\/10.1007\/s00280-005-0055-y","journal-title":"Cancer Chemother Pharmacol"},{"key":"3171_CR228","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31905","author":"MW Parsons","year":"2019","unstructured":"Parsons MW, Dietrich J (2019) Assessment and management of cognitive changes in patients with cancer. Cancer. https:\/\/doi.org\/10.1002\/cncr.31905","journal-title":"Cancer"},{"issue":"2","key":"3171_CR229","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1017\/s1355617709090316","volume":"15","author":"AD Pedersen","year":"2009","unstructured":"Pedersen AD, Rossen P, Mehlsen MY, Pedersen CG, Zachariae R, von der Maase H (2009) Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 15(2):296\u2013301. https:\/\/doi.org\/10.1017\/s1355617709090316","journal-title":"J Int Neuropsychol Soc"},{"issue":"1\u20132","key":"3171_CR230","first-page":"36","volume":"15","author":"JC Pendergrass","year":"2018","unstructured":"Pendergrass JC, Targum SD, Harrison JE (2018) Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci 15(1\u20132):36\u201344","journal-title":"Innov Clin Neurosci"},{"issue":"4","key":"3171_CR231","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#","volume":"79","author":"J Pereira","year":"1997","unstructured":"Pereira J, Hanson J, Bruera E (1997) The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79(4):835\u2013842","journal-title":"Cancer"},{"key":"3171_CR232","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-019-00038-2","author":"D Pergolizzi","year":"2019","unstructured":"Pergolizzi D, Root JC, Pan H et al (2019) Episodic memory for visual scenes suggests compensatory brain activity in breast cancer patients: a prospective longitudinal fMRI study. Brain Imaging Behav. https:\/\/doi.org\/10.1007\/s11682-019-00038-2","journal-title":"Brain Imaging Behav"},{"issue":"6","key":"3171_CR233","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000370117","volume":"88","author":"JF Piccirillo","year":"2015","unstructured":"Piccirillo JF, Hardin FM, Nicklaus J et al (2015) Cognitive impairment after chemotherapy related to atypical network architecture for executive control. Oncology 88(6):360\u2013368. https:\/\/doi.org\/10.1159\/000370117","journal-title":"Oncology"},{"issue":"4","key":"3171_CR234","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11682-013-9243-2","volume":"7","author":"KL Pomykala","year":"2013","unstructured":"Pomykala KL, Ganz PA, Bower JE et al (2013) The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav 7(4):511\u2013523. https:\/\/doi.org\/10.1007\/s11682-013-9243-2","journal-title":"Brain Imaging Behav"},{"issue":"6","key":"3171_CR235","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/gps.4189","volume":"30","author":"LL Ponto","year":"2015","unstructured":"Ponto LL, Menda Y, Magnotta VA, Yamada TH, Denburg NL, Schultz SK (2015) Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study. Int J Geriatr Psychiatry 30(6):587\u2013594. https:\/\/doi.org\/10.1002\/gps.4189","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"3171_CR236","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/07347332.2011.600751","volume":"29","author":"S Prokasheva","year":"2011","unstructured":"Prokasheva S, Faran Y, Cwikel J, Geffen DB (2011) Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test. J Psychosoc Oncol 29(5):499\u2013514. https:\/\/doi.org\/10.1080\/07347332.2011.600751","journal-title":"J Psychosoc Oncol"},{"key":"3171_CR237","first-page":"129","volume-title":"Neural signaling neuroscience","author":"D Purves","year":"2004","unstructured":"Purves D (2004) Neural signaling neuroscience, 3rd edn. Sinauer Associates, pp 129\u2013142","edition":"3"},{"issue":"1","key":"3171_CR238","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-008-0114-2","volume":"116","author":"C Quesnel","year":"2009","unstructured":"Quesnel C, Savard J, Ivers H (2009) Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat 116(1):113\u2013123. https:\/\/doi.org\/10.1007\/s10549-008-0114-2","journal-title":"Breast Cancer Res Treat"},{"key":"3171_CR239","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.breast.2017.01.018","volume":"32","author":"M Ramalho","year":"2017","unstructured":"Ramalho M, Fontes F, Ruano L, Pereira S, Lunet N (2017) Cognitive impairment in the first year after breast cancer diagnosis: a prospective cohort study. Breast 32:173\u2013178. https:\/\/doi.org\/10.1016\/j.breast.2017.01.018","journal-title":"Breast"},{"issue":"4","key":"3171_CR240","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/07347330903183117","volume":"27","author":"SA Reid-Arndt","year":"2009","unstructured":"Reid-Arndt SA, Yee A, Perry MC, Hsieh C (2009) Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. J Psychosoc Oncol 27(4):415\u2013434. https:\/\/doi.org\/10.1080\/07347330903183117","journal-title":"J Psychosoc Oncol"},{"key":"3171_CR241","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbadis.2019.02.007","volume":"6","author":"X Ren","year":"1865","unstructured":"Ren X, Boriero D, Chaiswing L, Bondada S, St Clair DK (1865) Butterfield DA (2019a) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta Mol Basis Dis 6:1088\u20131097. https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.007","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3171_CR242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.12.029","volume":"134","author":"X Ren","year":"2019","unstructured":"Ren X, Keeney JTR, Miriyala S et al (2019b) The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (\u201cchemobrain\u201d) involving TNF-alpha. Free Radic Biol Med 134:1\u20138. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.12.029","journal-title":"Free Radic Biol Med"},{"key":"3171_CR243","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","volume":"117","author":"X Ren","year":"2017","unstructured":"Ren X, St Clair DK, Butterfield DA (2017) Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol Res 117:267\u2013273. https:\/\/doi.org\/10.1016\/j.phrs.2017.01.001","journal-title":"Pharmacol Res"},{"issue":"3","key":"3171_CR244","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1385\/JMN:20:3:339","volume":"20","author":"A Rice","year":"2003","unstructured":"Rice A, Michaelis ML, Georg G, Liu Y, Turunen B, Audus KL (2003) Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors. J Mol Neurosci 20(3):339\u2013343. https:\/\/doi.org\/10.1385\/JMN:20:3:339","journal-title":"J Mol Neurosci"},{"issue":"5","key":"3171_CR245","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2354.2006.00736.x","volume":"16","author":"J Richardson","year":"2007","unstructured":"Richardson J, Smith J, McCall G, Richardson A, Pilkington K, Kirsch I (2007) Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Euro J Cancer Care 16(5):402\u2013412. https:\/\/doi.org\/10.1111\/j.1365-2354.2006.00736.x","journal-title":"Euro J Cancer Care"},{"key":"3171_CR246","doi-asserted-by":"crossref","unstructured":"Ruiz-Ojeda FJ, Olza J, Gil \u00c1, Aguilera CM (2018) Oxidative Stress and Inflammation in\u00a0Obesity and Metabolic Syndrome Obesity. p 1\u201315","DOI":"10.1016\/B978-0-12-812504-5.00001-5"},{"key":"3171_CR247","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1471-2407-6-274","volume":"6","author":"S Sadighi","year":"2006","unstructured":"Sadighi S, Mohagheghi MA, Montazeri A, Sadighi Z (2006) Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC Cancer 6:274. https:\/\/doi.org\/10.1186\/1471-2407-6-274","journal-title":"BMC Cancer"},{"issue":"1","key":"3171_CR248","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clcc.2018.09.002","volume":"18","author":"MVC Sales","year":"2019","unstructured":"Sales MVC, Suemoto CK, Apolinario D et al (2019) Effects of adjuvant chemotherapy on cognitive function of patients with early-stage colorectal cancer. Clin Colorectal Cancer 18(1):19\u201327. https:\/\/doi.org\/10.1016\/j.clcc.2018.09.002","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"3171_CR249","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00280-010-1429-3","volume":"67","author":"I Sardi","year":"2011","unstructured":"Sardi I, La Marca G, Giovannini MG et al (2011) Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry. Cancer Chemother Pharmacol 67(6):1333\u20131340. https:\/\/doi.org\/10.1007\/s00280-010-1429-3","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3171_CR250","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/02841860701518058","volume":"47","author":"SB Schagen","year":"2008","unstructured":"Schagen SB, Boogerd W, Muller MJ et al (2008) Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 47(1):63\u201370. https:\/\/doi.org\/10.1080\/02841860701518058","journal-title":"Acta Oncol"},{"issue":"2","key":"3171_CR251","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1023\/a:1010635229762","volume":"51","author":"SB Schagen","year":"2001","unstructured":"Schagen SB, Hamburger HL, Muller MJ, Boogerd W, van Dam FS (2001) Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 51(2):159\u2013165. https:\/\/doi.org\/10.1023\/a:1010635229762","journal-title":"J Neurooncol"},{"issue":"23","key":"3171_CR252","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/jnci\/djj470","volume":"98","author":"SB Schagen","year":"2006","unstructured":"Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, Van Dam FS (2006) Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 98(23):1742\u20131745. https:\/\/doi.org\/10.1093\/jnci\/djj470","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"3171_CR253","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1023\/a:101063522976","volume":"13","author":"SB Schagen","year":"2002","unstructured":"Schagen SB, Muller MJ, Boogerd W et al (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13(9):1387\u20131397. https:\/\/doi.org\/10.1023\/a:101063522976","journal-title":"Ann Oncol"},{"issue":"3","key":"3171_CR254","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G","volume":"85","author":"SB Schagen","year":"1999","unstructured":"Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85(3):640\u2013650","journal-title":"Cancer"},{"issue":"3","key":"3171_CR255","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/s130303169","volume":"13","author":"CS Scherling","year":"2013","unstructured":"Scherling CS, Smith A (2013) Opening up the window into \u201cchemobrain\u201d: a neuroimaging review. Sensors (basel) 13(3):3169\u20133203. https:\/\/doi.org\/10.3390\/s130303169","journal-title":"Sensors (basel)"},{"issue":"8","key":"3171_CR256","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1017\/s1355617720000296","volume":"26","author":"W Schrauwen","year":"2020","unstructured":"Schrauwen W, Van de Cavey J, Vingerhoets G, Vanheule S, Van den Broecke R, Denys H (2020) Heterogeneous response of chemotherapy-related cognitive decline in patients with breast cancer: a prospective study. J Int Neuropsychol Soc 26(8):806\u2013814. https:\/\/doi.org\/10.1017\/s1355617720000296","journal-title":"J Int Neuropsychol Soc"},{"issue":"3","key":"3171_CR257","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.neubiorev.2010.09.006","volume":"35","author":"R Seigers","year":"2011","unstructured":"Seigers R, Fardell JE (2011) Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 35(3):729\u2013741. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.09.006","journal-title":"Neurosci Biobehav Rev"},{"key":"3171_CR258","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbr.2015.10.057","volume":"299","author":"R Seigers","year":"2016","unstructured":"Seigers R, Loos M, Van Tellingen O, Boogerd W, Smit AB, Schagen SB (2016) Neurobiological changes by cytotoxic agents in mice. Behav Brain Res 299:19\u201326. https:\/\/doi.org\/10.1016\/j.bbr.2015.10.057","journal-title":"Behav Brain Res"},{"issue":"2","key":"3171_CR259","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","volume":"186","author":"R Seigers","year":"2008","unstructured":"Seigers R, Schagen SB, Beerling W et al (2008) Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 186(2):168\u2013175. https:\/\/doi.org\/10.1016\/j.bbr.2007.08.004","journal-title":"Behav Brain Res"},{"issue":"2","key":"3171_CR260","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.bbr.2009.02.025","volume":"201","author":"R Seigers","year":"2009","unstructured":"Seigers R, Schagen SB, Coppens CM et al (2009) Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 201(2):279\u2013284. https:\/\/doi.org\/10.1016\/j.bbr.2009.02.025","journal-title":"Behav Brain Res"},{"issue":"4","key":"3171_CR261","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11682-013-9250-3","volume":"7","author":"R Seigers","year":"2013","unstructured":"Seigers R, Schagen SB, Van Tellingen O, Dietrich J (2013) Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav 7(4):453\u2013459. https:\/\/doi.org\/10.1007\/s11682-013-9250-3","journal-title":"Brain Imaging Behav"},{"issue":"2","key":"3171_CR262","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/14740338.4.2.219","volume":"4","author":"K Seiter","year":"2005","unstructured":"Seiter K (2005) Toxicity of the topoisomerase II inhibitors. Expert Opin Drug Safety 4(2):219\u2013234. https:\/\/doi.org\/10.1517\/14740338.4.2.219","journal-title":"Expert Opin Drug Safety"},{"key":"3171_CR263","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.phymed.2018.10.022","volume":"55","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Klauck SM, Efferth T, Panossian A (2018) Adaptogens in chemobrain (Part I): Plant extracts attenuate cancer chemotherapy-induced cognitive impairment\u2014Transcriptome-wide microarray profiles of neuroglia cells. Phytomedicine 55:80\u201391. https:\/\/doi.org\/10.1016\/j.phymed.2018.10.022","journal-title":"Phytomedicine"},{"issue":"1","key":"3171_CR264","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41598-018-36380-6","volume":"9","author":"CY Shen","year":"2019","unstructured":"Shen CY, Chen VC, Yeh DC et al (2019) Association of functional dorsal attention network alterations with breast cancer and chemotherapy. Sci Rep 9(1):104. https:\/\/doi.org\/10.1038\/s41598-018-36380-6","journal-title":"Sci Rep"},{"issue":"19","key":"3171_CR265","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1200\/jco.2014.58.2320","volume":"33","author":"YC Shih","year":"2015","unstructured":"Shih YC, Smieliauskas F, Geynisman DM, Kelly RJ, Smith TJ (2015) Trends in the cost and use of targeted cancer therapies for the privately insured nonelderly: 2001 to 2011. J Clin Oncol 33(19):2190\u20132196. https:\/\/doi.org\/10.1200\/jco.2014.58.2320","journal-title":"J Clin Oncol"},{"issue":"1","key":"3171_CR266","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejon.2006.02.005","volume":"11","author":"V Shilling","year":"2007","unstructured":"Shilling V, Jenkins V (2007) Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 11(1):6\u201315. https:\/\/doi.org\/10.1016\/j.ejon.2006.02.005","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"3171_CR267","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.breast.2004.10.004","volume":"14","author":"V Shilling","year":"2005","unstructured":"Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D (2005) The effects of adjuvant chemotherapy on cognition in women with breast cancer\u2013preliminary results of an observational longitudinal study. Breast 14(2):142\u2013150. https:\/\/doi.org\/10.1016\/j.breast.2004.10.004","journal-title":"Breast"},{"issue":"3","key":"3171_CR268","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/155005949202300307","volume":"23","author":"T Siddiqui","year":"1992","unstructured":"Siddiqui T, Deshmukh VD, Karimjee N (1992) Subclinical cognitive deficits in cancer patients: a preliminary P300 study. Clin Electroencephalogr 23(3):132\u2013136","journal-title":"Clin Electroencephalogr"},{"issue":"3","key":"3171_CR269","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-006-9380-z","volume":"103","author":"DH Silverman","year":"2007","unstructured":"Silverman DH, Dy CJ, Castellon SA et al (2007) Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5\u201310\u00a0years after chemotherapy. Breast Cancer Res Treat 103(3):303\u2013311. https:\/\/doi.org\/10.1007\/s10549-006-9380-z","journal-title":"Breast Cancer Res Treat"},{"key":"3171_CR270","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.nicl.2017.12.032","volume":"18","author":"M Simo","year":"2018","unstructured":"Simo M, Gurtubay-Antolin A, Vaquero L, Bruna J, Rodriguez-Fornells A (2018) Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures. Neuroimage Clin 18:86\u201396. https:\/\/doi.org\/10.1016\/j.nicl.2017.12.032","journal-title":"Neuroimage Clin"},{"issue":"8","key":"3171_CR271","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.neubiorev.2013.04.015","volume":"37","author":"M Simo","year":"2013","unstructured":"Simo M, Rifa-Ros X, Rodriguez-Fornells A, Bruna J (2013) Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 37(8):1311\u20131321. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.04.015","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"3171_CR272","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/annonc\/mdq553","volume":"22","author":"T Skaali","year":"2011","unstructured":"Skaali T, Fossa SD, Andersson S et al (2011) A prospective study of neuropsychological functioning in testicular cancer patients. Ann Oncol 22(5):1062\u20131070. https:\/\/doi.org\/10.1093\/annonc\/mdq553","journal-title":"Ann Oncol"},{"issue":"7","key":"3171_CR273","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cncr.25685","volume":"117","author":"BJ Small","year":"2011","unstructured":"Small BJ, Rawson KS, Walsh E et al (2011) Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 117(7):1369\u20131376. https:\/\/doi.org\/10.1002\/cncr.25685","journal-title":"Cancer"},{"issue":"1","key":"3171_CR274","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87(1):10\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.10.004","journal-title":"Brain Res Bull"},{"key":"3171_CR275","volume-title":"Clinical neuroanatomy","author":"RS Snell","year":"2010","unstructured":"Snell RS (2010) Clinical neuroanatomy. Lippincott Williams & Wilkins"},{"issue":"1","key":"3171_CR276","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1097\/RLU.0b013e318292aa81","volume":"39","author":"J Sorokin","year":"2014","unstructured":"Sorokin J, Saboury B, Ahn JA, Moghbel M, Basu S, Alavi A (2014) Adverse functional effects of chemotherapy on whole-brain metabolism: a PET\/CT quantitative analysis of FDG metabolic pattern of the \u201cchemo-brain.\u201d Clin Nucl Med 39(1):e35\u2013e39. https:\/\/doi.org\/10.1097\/RLU.0b013e318292aa81","journal-title":"Clin Nucl Med"},{"issue":"2","key":"3171_CR277","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/pon.1210","volume":"17","author":"A Stewart","year":"2008","unstructured":"Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C (2008) The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psychooncology 17(2):122\u2013130. https:\/\/doi.org\/10.1002\/pon.1210","journal-title":"Psychooncology"},{"issue":"6a","key":"3171_CR278","first-page":"1945","volume":"13","author":"DJ Stewart","year":"1993","unstructured":"Stewart DJ, Grewaal D, Green RM et al (1993) Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer Res 13(6a):1945\u20131952","journal-title":"Anticancer Res"},{"issue":"11","key":"3171_CR279","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/hbm.22942","volume":"36","author":"MM Stouten-Kemperman","year":"2015","unstructured":"Stouten-Kemperman MM, de Ruiter MB, Caan MW et al (2015) Lower cognitive performance and white matter changes in testicular cancer survivors 10\u00a0years after chemotherapy. Hum Brain Mapp 36(11):4638\u20134647. https:\/\/doi.org\/10.1002\/hbm.22942","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"3171_CR280","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"3171_CR281","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10549-009-0606-8","volume":"123","author":"FA Tager","year":"2010","unstructured":"Tager FA, McKinley PS, Schnabel FR et al (2010) The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat 123(1):25\u201334. https:\/\/doi.org\/10.1007\/s10549-009-0606-8","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3171_CR282","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2006.02.013","volume":"23","author":"J Tangpong","year":"2006","unstructured":"Tangpong J, Cole MP, Sultana R et al (2006) Adriamycin-induced, TNF-\u03b1-mediated central nervous system toxicity. Neurobiol Dis 23(1):127\u2013139. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.013","journal-title":"Neurobiol Dis"},{"key":"3171_CR283","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuroscience.2010.11.007","volume":"175","author":"J Tangpong","year":"2011","unstructured":"Tangpong J, Miriyala S, Noel T, Sinthupibulyakit C, Jungsuwadee P, St Clair DK (2011) Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience 175:292\u2013299. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.11.007","journal-title":"Neuroscience"},{"key":"3171_CR284","doi-asserted-by":"publisher","unstructured":"Tao L, Lin H, Yan Y, et al. (2017) Impairment of the executive function in breast cancer patients receiving chemotherapy treatment: a functional MRI study. Eur J Cancer Care (Engl) 26(6) doi:https:\/\/doi.org\/10.1111\/ecc.12553","DOI":"10.1111\/ecc.12553"},{"key":"3171_CR285","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3389\/fpsyg.2020.01689","volume":"11","author":"L Tao","year":"2020","unstructured":"Tao L, Wang L, Chen X et al (2020) Modulation of Interhemispheric functional coordination in breast cancer patients receiving chemotherapy. Front Psychol 11:1689. https:\/\/doi.org\/10.3389\/fpsyg.2020.01689","journal-title":"Front Psychol"},{"issue":"22","key":"3171_CR286","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/jco.2003.01.119","volume":"21","author":"N Tchen","year":"2003","unstructured":"Tchen N, Juffs HG, Downie FP et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21(22):4175\u20134183. https:\/\/doi.org\/10.1200\/jco.2003.01.119","journal-title":"J Clin Oncol"},{"key":"3171_CR287","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2017.07.003","volume":"1672","author":"TC Thomas","year":"2017","unstructured":"Thomas TC, Beitchman JA, Pomerleau F et al (2017) Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Res 1672:10\u201317. https:\/\/doi.org\/10.1016\/j.brainres.2017.07.003","journal-title":"Brain Res"},{"issue":"6","key":"3171_CR288","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/09168451.2020.1722057","volume":"84","author":"Y Tong","year":"2020","unstructured":"Tong Y, Wang K, Sheng S, Cui J (2020) Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats. Biosci Biotechnol Biochem 84(6):1201\u20131210. https:\/\/doi.org\/10.1080\/09168451.2020.1722057","journal-title":"Biosci Biotechnol Biochem"},{"issue":"8","key":"3171_CR289","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/ars.2007.1957","volume":"10","author":"D Trachootham","year":"2008","unstructured":"Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343\u20131374. https:\/\/doi.org\/10.1089\/ars.2007.1957","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3171_CR290","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/138161210789941847","volume":"16","author":"A Urruticoechea","year":"2010","unstructured":"Urruticoechea A, Alemany R, Balart J, Villanueva A, Vi\u00f1als F, Capella G (2010) Recent advances in cancer therapy: an overview. Curr Pharmaceutical Des 16(1):3\u201310. https:\/\/doi.org\/10.2174\/138161210789941847","journal-title":"Curr Pharmaceutical Des"},{"key":"3171_CR291","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejon.2018.08.006","volume":"36","author":"I Utne","year":"2018","unstructured":"Utne I, Loyland B, Grov EK et al (2018) Distinct attentional function profiles in older adults receiving cancer chemotherapy. Eur J Oncol Nurs 36:32\u201339. https:\/\/doi.org\/10.1016\/j.ejon.2018.08.006","journal-title":"Eur J Oncol Nurs"},{"issue":"3","key":"3171_CR292","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","volume":"90","author":"FS van Dam","year":"1998","unstructured":"van Dam FS, Schagen SB, Muller MJ et al (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90(3):210\u2013218","journal-title":"J Natl Cancer Inst"},{"key":"3171_CR293","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41523-018-0076-4","volume":"4","author":"K Van Dyk","year":"2018","unstructured":"Van Dyk K, Bower JE, Crespi CM, Petersen L, Ganz PA (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25. https:\/\/doi.org\/10.1038\/s41523-018-0076-4","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"3171_CR294","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1017\/s1355617709990567","volume":"15","author":"KJ Vearncombe","year":"2009","unstructured":"Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G (2009) Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc 15(6):951\u2013962. https:\/\/doi.org\/10.1017\/s1355617709990567","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"3171_CR295","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12149-019-01331-2","volume":"33","author":"T Vitor","year":"2019","unstructured":"Vitor T, Kozasa EH, Bressan RA et al (2019) Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1. Ann Nucl Med 33(4):269\u2013279. https:\/\/doi.org\/10.1007\/s12149-019-01331-2","journal-title":"Ann Nucl Med"},{"issue":"4","key":"3171_CR296","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/13854040802541439","volume":"23","author":"D Von Ah","year":"2009","unstructured":"Von Ah D, Harvison KW, Monahan PO et al (2009) Cognitive function in breast cancer survivors compared to healthy age- and education-matched women. Clin Neuropsychol 23(4):661\u2013674. https:\/\/doi.org\/10.1080\/13854040802541439","journal-title":"Clin Neuropsychol"},{"key":"3171_CR297","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104777","volume":"138","author":"SA Wahdan","year":"2020","unstructured":"Wahdan SA, El-Derany MO, Abdel-Maged AE, Azab SS (2020) Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks. Neurochem Int 138:104777. https:\/\/doi.org\/10.1016\/j.neuint.2020.104777","journal-title":"Neurochem Int"},{"issue":"2","key":"3171_CR298","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11064-020-03164-2","volume":"46","author":"C Wang","year":"2021","unstructured":"Wang C, Zhao Y, Wang L et al (2021) C-phycocyanin mitigates cognitive impairment in doxorubicin-induced chemobrain: impact on neuroinflammation, oxidative stress, and brain mitochondrial and synaptic alterations. Neurochem Res 46(2):149\u2013158. https:\/\/doi.org\/10.1007\/s11064-020-03164-2","journal-title":"Neurochem Res"},{"issue":"11","key":"3171_CR299","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1007\/s11064-019-02882-6","volume":"44","author":"D Wang","year":"2019","unstructured":"Wang D, Wang B, Liu Y, Dong X, Su Y, Li S (2019) Protective effects of ACY-1215 against chemotherapy-related cognitive impairment and brain damage in mice. Neurochem Res 44(11):2460\u20132469. https:\/\/doi.org\/10.1007\/s11064-019-02882-6","journal-title":"Neurochem Res"},{"issue":"2","key":"3171_CR300","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cncr.29737","volume":"122","author":"L Wang","year":"2016","unstructured":"Wang L, Apple AC, Schroeder MP et al (2016) Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls. Cancer 122(2):258\u2013268. https:\/\/doi.org\/10.1002\/cncr.29737","journal-title":"Cancer"},{"issue":"3","key":"3171_CR301","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.acra.2019.04.010","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Zou L, Chen Q et al (2020) Gray matter structural network disruptions in survivors of acute lymphoblastic leukemia with chemotherapy treatment. Acad Radiol 27(3):e27\u2013e34. https:\/\/doi.org\/10.1016\/j.acra.2019.04.010","journal-title":"Acad Radiol"},{"issue":"1","key":"3171_CR302","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","volume":"72","author":"XM Wang","year":"2015","unstructured":"Wang XM, Walitt B, Saligan L, Tiwari AF, Cheung CW, Zhang ZJ (2015) Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine 72(1):86\u201396. https:\/\/doi.org\/10.1016\/j.cyto.2014.12.006","journal-title":"Cytokine"},{"issue":"3","key":"3171_CR303","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cncr.20393","volume":"101","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA (2004a) \u201cChemobrain\u201d in breast carcinoma? a prologue. Cancer 101(3):466\u2013475. https:\/\/doi.org\/10.1002\/cncr.20393","journal-title":"Cancer"},{"issue":"11","key":"3171_CR304","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/cncr.20272","volume":"100","author":"JS Wefel","year":"2004","unstructured":"Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA (2004b) The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100(11):2292\u20132299. https:\/\/doi.org\/10.1002\/cncr.20272","journal-title":"Cancer"},{"issue":"14","key":"3171_CR305","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1002\/cncr.25098","volume":"116","author":"JS Wefel","year":"2010","unstructured":"Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14):3348\u20133356. https:\/\/doi.org\/10.1002\/cncr.25098","journal-title":"Cancer"},{"issue":"5","key":"3171_CR306","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuro.2008.03.009","volume":"29","author":"B Weiss","year":"2008","unstructured":"Weiss B (2008) Chemobrain: a translational challenge for neurotoxicology. Neurotoxicology 29(5):891\u2013898. https:\/\/doi.org\/10.1016\/j.neuro.2008.03.009","journal-title":"Neurotoxicology"},{"issue":"3","key":"3171_CR307","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJM197407182910305","volume":"291","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wiernik PH (1974a) Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 291(3):127\u2013133","journal-title":"N Engl J Med"},{"issue":"3","key":"3171_CR308","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/nejm197407182910305","volume":"291","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wiernik PH (1974b) Neurotoxicity of commonly used antineoplastic agents (second of two parts). New Engl J Med 291(3):127\u2013133. https:\/\/doi.org\/10.1056\/nejm197407182910305","journal-title":"New Engl J Med"},{"key":"3171_CR309","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05095-3","author":"HS Whitford","year":"2019","unstructured":"Whitford HS, Kalinowski P, Schembri A et al (2019) The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-019-05095-3","journal-title":"Support Care Cancer"},{"issue":"7","key":"3171_CR310","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s00520-019-05095-3","volume":"28","author":"HS Whitford","year":"2020","unstructured":"Whitford HS, Kalinowski P, Schembri A et al (2020) The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Support Care Cancer 28(7):3081\u20133091. https:\/\/doi.org\/10.1007\/s00520-019-05095-3","journal-title":"Support Care Cancer"},{"issue":"1","key":"3171_CR311","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pon.2960040108","volume":"4","author":"MH Wieneke","year":"1995","unstructured":"Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncol 4(1):61\u201366","journal-title":"Psycho-Oncol"},{"key":"3171_CR312","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4419-6306-2_20","volume":"678","author":"PM Wigmore","year":"2010","unstructured":"Wigmore PM, Mustafa S, El-Beltagy M, Lyons L, Umka J, Bennett G (2010) Effects of 5-FU. Adv Exp Med Biol 678:157\u2013164. https:\/\/doi.org\/10.1007\/978-1-4419-6306-2_20","journal-title":"Adv Exp Med Biol"},{"key":"3171_CR313","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.10.005","volume":"314","author":"AM Williams","year":"2018","unstructured":"Williams AM, Shah R, Shayne M et al (2018) Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. J Neuroimmunol 314:17\u201323. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.10.005","journal-title":"J Neuroimmunol"},{"issue":"7","key":"3171_CR314","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1080\/10428194.2020.1728748","volume":"61","author":"AM Williams","year":"2020","unstructured":"Williams AM, van Wijngaarden E, Seplaki CL et al (2020) Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment. Leuk Lymphoma 61(7):1627\u20131635. https:\/\/doi.org\/10.1080\/10428194.2020.1728748","journal-title":"Leuk Lymphoma"},{"issue":"9\u201310","key":"3171_CR315","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/0284186x.2016.1189092","volume":"55","author":"H Wouters","year":"2016","unstructured":"Wouters H, Baars JW, Schagen SB (2016) Neurocognitive function of lymphoma patients after treatment with chemotherapy. Acta Oncol 55(9\u201310):1121\u20131125. https:\/\/doi.org\/10.1080\/0284186x.2016.1189092","journal-title":"Acta Oncol"},{"issue":"1","key":"3171_CR316","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00280-019-03994-0","volume":"85","author":"Z Xu","year":"2020","unstructured":"Xu Z, Luo F, Wang Y et al (2020) Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials. Cancer Chemother Pharmacol 85(1):61\u201367. https:\/\/doi.org\/10.1007\/s00280-019-03994-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3171_CR317","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1176\/appi.neuropsych.22.1.48","volume":"22","author":"TH Yamada","year":"2010","unstructured":"Yamada TH, Denburg NL, Beglinger LJ, Schultz SK (2010) Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J Neuropsychiatry Clin Neurosci 22(1):48\u201354. https:\/\/doi.org\/10.1176\/appi.neuropsych.22.1.48","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"3171_CR318","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/15592294.2019.1699695","volume":"15","author":"GS Yang","year":"2020","unstructured":"Yang GS, Mi X, Jackson-Cook CK et al (2020) Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year. Epigenetics 15(5):499\u2013510. https:\/\/doi.org\/10.1080\/15592294.2019.1699695","journal-title":"Epigenetics"},{"issue":"1","key":"3171_CR319","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H et al (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37(1):266\u2013266. https:\/\/doi.org\/10.1186\/s13046-018-0909-x","journal-title":"J Exp Clin Cancer Res"},{"issue":"1\u20132","key":"3171_CR320","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainresbull.2012.07.003","volume":"89","author":"M Yang","year":"2012","unstructured":"Yang M, Kim JS, Kim J et al (2012) Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Res Bull 89(1\u20132):50\u201356. https:\/\/doi.org\/10.1016\/j.brainresbull.2012.07.003","journal-title":"Brain Res Bull"},{"issue":"11","key":"3171_CR321","first-page":"18","volume":"6","author":"A Yarlagadda","year":"2009","unstructured":"Yarlagadda A, Alfson E, Clayton AH (2009) The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (edgmont) 6(11):18\u201322","journal-title":"Psychiatry (edgmont)"},{"issue":"5","key":"3171_CR322","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.3892\/ol.2017.6931","volume":"14","author":"C Yokoyama","year":"2017","unstructured":"Yokoyama C, Sueyoshi Y, Ema M, Mori Y, Takaishi K, Hisatomi H (2017) Induction of oxidative stress by anticancer drugs in the presence and absence of cells. Oncol Lett 14(5):6066\u20136070. https:\/\/doi.org\/10.3892\/ol.2017.6931","journal-title":"Oncol Lett"},{"issue":"1","key":"3171_CR323","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12885-019-5576-6","volume":"19","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Cheng ASK, Song T et al (2019) Changes in functional brain networks and neurocognitive function in Chinese gynecological cancer patients after chemotherapy: a prospective longitudinal study. BMC Cancer 19(1):386. https:\/\/doi.org\/10.1186\/s12885-019-5576-6","journal-title":"BMC Cancer"},{"issue":"2","key":"3171_CR324","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"J-M Zhang","year":"2007","unstructured":"Zhang J-M, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45(2):27\u201337. https:\/\/doi.org\/10.1097\/AIA.0b013e318034194e","journal-title":"Int Anesthesiol Clin"},{"issue":"3","key":"3171_CR325","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/dmd.114.061820","volume":"43","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang L, Yan Y et al (2015) Are capecitabine and the active metabolite 5-FU CNS penetrable to treat breast cancer brain metastasis? Drug Metab Disposition 43(3):411\u2013417. https:\/\/doi.org\/10.1124\/dmd.114.061820","journal-title":"Drug Metab Disposition"},{"key":"3171_CR326","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-018-0030-y","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen YC, Hu L et al (2019) Chemotherapy-induced functional changes of the default mode network in patients with lung cancer. Brain Imaging Behav. https:\/\/doi.org\/10.1007\/s11682-018-0030-y","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"3171_CR327","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10549-014-3044-1","volume":"146","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Luo J, Bao P et al (2014) Long-term cognitive function change among breast cancer survivors. Breast Cancer Res Treat 146(3):599\u2013609. https:\/\/doi.org\/10.1007\/s10549-014-3044-1","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3171_CR328","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151890","volume":"11","author":"W Zhou","year":"2016","unstructured":"Zhou W, Kavelaars A, Heijnen CJ (2016) Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS ONE 11(3):e0151890. https:\/\/doi.org\/10.1371\/journal.pone.0151890","journal-title":"PLoS ONE"},{"key":"3171_CR329","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.freeradbiomed.2018.10.418","volume":"129","author":"X Zhou","year":"2018","unstructured":"Zhou X, Xu P, Dang R et al (2018) The involvement of autophagic flux in the development and recovery of doxorubicin-induced neurotoxicity. Free Radical Biol Med 129:440\u2013445. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.418","journal-title":"Free Radical Biol Med"},{"issue":"4","key":"3171_CR330","first-page":"529","volume":"17","author":"M Zimberg","year":"1990","unstructured":"Zimberg M, Berenson S (1990) Delirium in patients with cancer: nursing assessment and intervention. Oncol Nurs Forum 17(4):529\u2013538","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"3171_CR331","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5(6):311. https:\/\/doi.org\/10.1038\/nrneurol.2009.54","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"3171_CR332","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jgo.2017.10.004","volume":"9","author":"KE Zuniga","year":"2018","unstructured":"Zuniga KE, Bishop NJ (2018) Recent cancer treatment and memory decline in older adults: An analysis of the 2002\u20132012 Health and Retirement Study. J Geriatr Oncol 9(3):186\u2013193. https:\/\/doi.org\/10.1016\/j.jgo.2017.10.004","journal-title":"J Geriatr Oncol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03171-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03171-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03171-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T18:35:06Z","timestamp":1641926106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03171-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":332,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3171"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03171-4","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"13 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}